Hemos leído sobre ... Uveítis
-
Chang MH, Barbar-Smiley F, Akoghlanian S, Drew J, Angeles-Han ST, Quinlan-Waters M, et al; CARRA Uveitis Workgroup and the CARRA Registry Investigators.
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.
Pediatr Rheumatol Online J. 2024 Oct 7;22(1):88. doi: 10.1186/s12969-024-01022-x.
https://pubmed.ncbi.nlm.nih.gov/39375683/ -
Bajraktari G, Jukić T, Kalauz M, Oroz M, Bertetić AR, Vukojević N.
Evaluation of postoperative outcomes after cataract surgery in patients with Juvenile Idiopathic Arthritis-Associated Uveitis.
Eur J Ophthalmol. 2024 Oct 15:11206721241290272. doi: 10.1177/11206721241290272. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39403026/
-
Lavallee C, Ahrens M, Davidson S, Goheer H, Shuster A, Lerman MA.
Measurable Outcomes of an Ophthalmology and Rheumatology Coordinated Care Clinic.
Arthritis Care Res (Hoboken). 2024 Sep 15. doi: 10.1002/acr.25433. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39279137/ -
Juan HY, Sheu SJ, Hwang DK.
Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis.
J Ocul Pharmacol Ther. 2024 Sep 24. doi: 10.1089/jop.2024.0100. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39315932/ -
Shah SM, Prabhu P, Biswas J.
Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis.
Indian J Ophthalmol. 2024 Sep 19. doi: 10.4103/IJO.IJO_712_24. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39297478/ -
Stolowy N, Aulanier A, Osswald D, Zanin E, Benso C, Attia R, et al.
Serum angiotensin-converting enzyme has low diagnostic value for pediatric sarcoid uveitis.
J Fr Ophtalmol. 2024 Sep 20;47(9):104292. doi: 10.1016/j.jfo.2024.104292. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39305654/ -
Maccora I, Simonini G, Guly CM, Ramanan AV.
Management of JIA associated uveitis.
Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101979. doi: 10.1016/j.berh.2024.101979.
https://pubmed.ncbi.nlm.nih.gov/39048481/ -
Nasir S, Ali MH, Patel A, Kelgaonkar A, Nayak S, Tyagi M, Murthy S, Basu S.
Visual Impairment at Presentation in Pediatric Uveitis: A Multicentric Study in 477 Children Across Southern and Eastern India.
Ocul Immunol Inflamm. 2024 Sep 11:1-5. doi: 10.1080/09273948.2024.2401134. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39259662/
-
Khan S, Saigal K, Sheth S, Maleki A.
Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis.
Ocul Immunol Inflamm. 2024 Aug 29:1-5. doi: 10.1080/09273948.2024.2391985.
https://pubmed.ncbi.nlm.nih.gov/39207387/
-
Del-Prado-Sánchez C, Llorca-Cardeñosa A, Yeste-Mayoral B, Grixolli-Mazzon S, Barros-Centeno MF, Díaz-Cascajosa J, Antón J, Calzada-Hernández J, Mosquera JM, Carriqui S, Zacarías A, Morales-Ballús M.
Optical coherence tomography for the screening of anterior chamber inflammation in paediatric patients diagnosed with juvenile idiopathic arthritis.
Clin Exp Rheumatol. 2024 Jul;42(7):1507-1512. doi: 10.55563/clinexprheumatol/t7pn4v. Epub 2024 May 21.
https://pubmed.ncbi.nlm.nih.gov/38819950/ -
Tordoff M, Smith SL, Lawson-Tovey S; UK JIA Biologics Register, CAPS, CHARMS, CLUSTER, JIAGC; Dick AD, Beresford MW, Ramanan AV, Hyrich KL, Morris AP, Eyre S, Wedderburn LR, Bowes J; CLUSTER consortium.
Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis.
Arthritis Rheumatol. 2024 Jul 19. doi: 10.1002/art.42955. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39030878/ -
Maccora I, Accardo V, Cattalini M, Pagnini I, Taddio A, Marrani E, La Torre F, Mastrolia MV, Bellicini I, Pastore S, Simonini G.
Uveitis as predictor of disease flare after the first anti-TNF withdrawal in oligoarticular and polyarticular juvenile idiopathic arthritis: a multicentric Italian experience.
Clin Exp Rheumatol. 2024 Jul 4. doi: 10.55563/clinexprheumatol/3mxsll. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38976296/ -
Gonçalves H, Alves S, Correia-Costa L, Miranda V, Zilhão C.
Non-infectious uveitis referred for pediatric rheumatologic assessment and management: A Portuguese retrospective study.
Mod Rheumatol. 2024 Jul 6;34(4):798-805. doi: 10.1093/mr/road083.
https://pubmed.ncbi.nlm.nih.gov/37572107/ -
Koru L, Esen F, Turkyilmaz O, Kucuk E, Kaya F, Aydin Z, Haslak F, Ozturk K.
Clinical characteristics of pediatric noninfectious uveitis and risk factors for severe disease: a single-center study.
Clin Rheumatol. 2024 Jul 27. doi: 10.1007/s10067-024-07072-6. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39066867/
-
Sota J, Guerriero S, Lopalco G, Tufan A, Ragab G, AlMaglouth I, et al.
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders.
Ocul Immunol Inflamm. 2024 May 17:1-8. doi: 10.1080/09273948.2024.2346815.
https://pubmed.ncbi.nlm.nih.gov/38759215/
-
Foeldvari I, Bohn M, Petrushkin H, Angeles Han S, Bangsgaard R, Calzada-Hernández J, Constantin T, de Boer JH, Díaz-Cascajosa J, Edelsten C, Glerup M, Ingels H, Kramer S, Miserocchi E, Nordal E, Saurenmann RK, Simonini G, Solebo AL, Titz J, Anton J.
A practical approach to uveitis screening in children with juvenile idiopathic arthritis.
Br J Ophthalmol. 2024 Apr 4:bjo-2023-324406. doi: 10.1136/bjo-2023-324406. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38575198/
-
Dutta Majumder P, Abraham S, Sudharshan S, Janarthanan M, Ramanan AV.
Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series.
Ocul Immunol Inflamm. 2024 Mar 5:1-4. doi: 10.1080/09273948.2024.2323671. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38441607/ -
Tarsia M, Vitale A, Gaggiano C, Sota J, Maselli A, Bellantonio C,et al.
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry.
Ophthalmol Ther. 2024 Mar;13(3):761-774. doi: 10.1007/s40123-023-00863-1
https://pubmed.ncbi.nlm.nih.gov/38206518/ -
Zhong L, Wang W, Tang X, Zhang Y, Gou L, Wang L, et al.
Phenotype of Takayasu-like vasculitis and cardiopathy in patients with Blau syndrome.
Clin Rheumatol. 2024 Mar;43(3):1171-1181. doi: 10.1007/s10067-024-06876-w.
https://pubmed.ncbi.nlm.nih.gov/38253779/ -
Yargi-Ozkocak B, Altan C, Kemer-Atik B, Basarir B.
Evaluation of Optical Coherence Tomography Angiography Findings in Pars Planitis and Multiple Sclerosis Associated Intermediate Uveitis in Remission.
Curr Eye Res. 2024 Mar 3:1-8. doi: 10.1080/02713683.2024.2323520. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/38433455/ -
Garbrecht JL, Powell ZR, McClard CK, Noori J.
Frosted branch angiitis in a patient with systemic juvenile idiopathic arthritis: a case report.
BMC Ophthalmol. 2024 Mar 5;24(1):106. doi: 10.1186/s12886-024-03373-1.
https://pubmed.ncbi.nlm.nih.gov/38443873/
-
Chen WD, Wu CH, Wu PY, Lin CP, Ou LS, Hwang DK, et al.
Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis.
J Formos Med Assoc. 2024 Feb 28:S0929-6646(24)00110-4. doi: 10.1016/j.jfma.2024.02.010.
https://pubmed.ncbi.nlm.nih.gov/38423923/ -
Mapelli C, Miserocchi E, Nassisi M, Beretta GB, Marelli L, Leone G, Marino A, Chighizola C, Cincinelli G, Giani T, Nucci P, Viola F, Filocamo G, Minoia F.
Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis.
Rheumatology (Oxford). 2024 Feb 8:keae079. doi: 10.1093/rheumatology/keae079.
https://pubmed.ncbi.nlm.nih.gov/38331409/ -
Zhang J, Zhou P, Hu S, Cai S, He T.
Causal inference between serum bilirubin levels and juvenile idiopathic arthritis-associated uveitis: A bidirectional Mendelian randomization study.
Health Sci Rep. 2024 Feb 1;7(2):e1847. doi: 10.1002/hsr2.1847.
https://pubmed.ncbi.nlm.nih.gov/38313187/ -
Rojas-Carabali W, Mejía-Salgado G, Villabona-Martínez V, Barraquer-López D, Cifuentes-González C, Marroquín G, Guarnizo Zuccardi PDR, de-la-Torre A.
Uveitis and Dry Eye Disease in Children: A Cross-Sectional Comparative Study.
Ocul Immunol Inflamm. 2024 Feb 20:1-7. doi: 10.1080/09273948.2024.2317416.
https://pubmed.ncbi.nlm.nih.gov/38376892/
-
Nguyen AT, Koné-Paut I, Dusser P.
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients.
Paediatr Drugs. 2024 Jan;26(1):31-47. doi: 10.1007/s40272-023-00596-5.
https://pubmed.ncbi.nlm.nih.gov/37792254/ -
Tungsattayathitthan U, Tesavibul N, Choopong P, Treeratsakulchai C, Ngathaweesuk Y, Sanphan W, Boonsopon S.
Efficacy of golimumab in patients with refractory non-infectious panuveitis.
Sci Rep. 2024 Jan 25;14(1):2179. doi: 10.1038/s41598-024-52526-1.
https://pubmed.ncbi.nlm.nih.gov/38273077/ -
Ede K, Shishov M, Wershba E, Goswami N, Gorry S, Joseph M, Mirea L, O'Neil J.
Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational study.
Pediatr Rheumatol Online J. 2024 Jan 26;22(1):22. doi: 10.1186/s12969-024-00961-9.
https://pubmed.ncbi.nlm.nih.gov/38279120/
-
Marino A, Marelli L, Nucci P, Caporali R, Miserocchi E.
Subcutaneous Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis.
Ocul Immunol Inflamm. 2023 Dec;31(10):1997-2000. doi: 10.1080/09273948.2022.2161916.
https://pubmed.ncbi.nlm.nih.gov/36657742/ - Huard J, Mihailescu SD, Muraine M, Raymond S, Grall Lerosey M, Gueudry J.
Effectiveness and Safety of Weekly Adalimumab for Non-Infectious Chronic Anterior Uveitis in Children.
Ocul Immunol Inflamm. 2023 Dec;31(10):2039-2049. doi: 10.1080/09273948.2023.2279682.
https://pubmed.ncbi.nlm.nih.gov/37972236/ -
Khochtali S, Ozdal P, AlBloushi AF, Nabi W, Khairallah M.
Pediatric Pars Planitis: A Review.
Ocul Immunol Inflamm. 2023 Dec;31(10):1915-1929. doi: 10.1080/09273948.2023.2279683.
https://pubmed.ncbi.nlm.nih.gov/37976519/ -
Maghsoudlou P, Abraham AR, El-Ashry M, Chew C, Mohd N, Ramanan AV, Dick AD.
Uveitis Associated with Monogenic Autoinflammatory Syndromes in Children.
Ocul Immunol Inflamm. 2023 Dec;31(10):1930-1943. doi: 10.1080/09273948.2023.2282610.
https://pubmed.ncbi.nlm.nih.gov/38051595/ -
Yalçındağ FN, Özdal P, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I; BUST Study Group.
Pediatric Uveitis in Turkey: The National Registry Report II.
Ocul Immunol Inflamm. 2023 Dec;31(10):1971-1977. doi: 10.1080/09273948.2022.2110900.
https://pubmed.ncbi.nlm.nih.gov/36083691/ -
Janetos TM, Lee PHA, Goldstein DA.
Tubulointerstitial Nephritis and Uveitis Syndrome in Pediatric Patients.
Ocul Immunol Inflamm. 2023 Dec;31(10):1955-1964. doi: 10.1080/09273948.2023.2279689.
https://pubmed.ncbi.nlm.nih.gov/37983806/ -
Dehoorne JL, Groth H, Carlé E, De Schrijver I, Sys C, Delbeke P, Kreps EO, Renson T, Bonroy C.
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment.
Pediatr Rheumatol Online J. 2023 Dec 20;21(1):148. doi: 10.1186/s12969-023-00928-2.
https://pubmed.ncbi.nlm.nih.gov/38124137/
-
van Meerwijk C, Kuiper J, van Straalen J, Ayuso VK, Wennink R, Haasnoot AM, Kouwenberg C, de Boer J.
Uveitis Associated with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2023 Nov 15:1-9. doi: 10.1080/09273948.2023.2278060.
https://pubmed.ncbi.nlm.nih.gov/37966463/ -
Gentile P, Ragusa E, Bolletta E, De Simone L, Gozzi F, Cappella M, Fastiggi M, De Fanti A, Cimino L.
Epidemiology of Pediatric Uveitis.
Ocul Immunol Inflamm. 2023 Nov 3:1-10. doi: 10.1080/09273948.2023.2271988.
https://pubmed.ncbi.nlm.nih.gov/37922466/ -
Fukuda Y, Yawata N, Hasegawa E, Yamana S, Shirane M, Ito T, Takeda A, Sonoda M, Eguchi K, Ishimura M, Ohga S, Sonoda KH.
Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in the Western Region of Japan.
Ocul Immunol Inflamm. 2023 Nov 2:1-7. doi: 10.1080/09273948.2023.2273363.
https://pubmed.ncbi.nlm.nih.gov/37917805/ -
Foeldvari I, Petrushkin H.
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?
Expert Rev Clin Immunol. 2023 Nov 21:1-10. doi: 10.1080/1744666X.2023.2284845.
https://pubmed.ncbi.nlm.nih.gov/37990508/
-
Nguyen AT, Koné-Paut I, Dusser P.
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients.
Paediatr Drugs. 2023 Oct 4. doi: 10.1007/s40272-023-00596-5. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37792254/ -
Kouwenberg CV, Spierings J, de Groot EL, de Boer JH, Kalinina Ayuso V.
Involvement of the systemic microcirculation in pediatric uveitis.
Pediatr Rheumatol Online J. 2023 Oct 2;21(1):109. doi: 10.1186/s12969-023-00896-7.
https://pubmed.ncbi.nlm.nih.gov/37784087/
-
Burlo F, Tumminelli C, Pastore S, Stocco G, Curci D, Lucafò M, et al.
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report.
Pediatr Rheumatol Online J. 2023 Sep 12;21(1):99. doi: 10.1186/s12969-023-00883-y.
https://pubmed.ncbi.nlm.nih.gov/37700264/ -
Fonollosa A, Pelegrín L, García-Morillo S, Buján-Rivas S, Distefano L, Robles-Maruenda A, Fernández-Martín J, González-García A, Garcia-Aparicio Á, Ortego-Centeno N, Llorenç V, Sainz de la Maza M, Pinedo C, Sopeña B, Cocho L, Carreño E, Blanco R, Antón J, Pérez-Quintana M, Marques-Soares JR, Artaraz J, Ruiz-Arruza I, Soto-Peleteiro A, Gómez-Caverzaschi V, Araújo O, Espinosa G, Adan A, Fabiani C, Cantarini L, Hernández-Rodríguez J; Spanish Society of Ocular Inflammation (SEIOC) and the AutoInflammatory Diseases Alliance (AIDA) Network.
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.
Clin Exp Rheumatol. 2023 Sep 28. doi: 10.55563/clinexprheumatol/ukegcc. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37812477/ -
Değirmenci MFK, Yalçındağ FN.
Are optical coherence tomography and fluorescein angiography comparable for detection of macular edema in Behçet uveitis?
Graefes Arch Clin Exp Ophthalmol. 2023 Sep 29. doi: 10.1007/s00417-023-06249-0. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37773289/ -
Gupta RB, Ilin J, Gottlieb CC.
Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective análisis
J Ophthalmic Inflamm Infect. 2023 Sep 18;13(1):42. doi: 10.1186/s12348-023-00360-3.
https://pubmed.ncbi.nlm.nih.gov/37721556/ -
Kemer Atik B, Altan C, Yargı Özkoçak B, Basarir B.
Clinical Features and Course in Patients Diagnosed with Ocular Sarcoidosis without Previously Known Systemic Disease at a Tertiary Referral Center in Turkey
Ocul Immunol Inflamm. 2023 Sep 27:1-7. doi: 10.1080/09273948.2023.2258397. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37756621/ -
Yılmaz Tuğan B, Sarıhan M, Kasap M, Akpınar G, Karabaş L, Şahin N, et al
Is tear proteome profile a predictor of developing uveitis in ANA-positive patients with oligoarticular juvenile idiopathic arthritis?
Graefes Arch Clin Exp Ophthalmol. 2023 Sep 29. doi: 10.1007/s00417-023-06251-6. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37773290/
-
Vitale A, Casa FD, Guerriero S, Ragab G, Mauro A, Caggiano V, et al.
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry.
Ophthalmol Ther. 2023 Aug;12(4):1957-1971. doi: 10.1007/s40123-023-00712-1. Epub 2023 May 11.
https://pubmed.ncbi.nlm.nih.gov/37166627/ -
Evereklioglu C, Sonmez HK, Sevim DG, Arda H, Sener H, Polat OA, Horozoglu F.
Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation.
Int Ophthalmol. 2023 Aug 9. doi: 10.1007/s10792-023-02846-4. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37555889/ -
Gonçalves HJB, Zilhão C, Miranda V, Alves S, Correia L.
Non-infectious uveitis referred for pediatric rheumatologic assessment and management: a Portuguese retrospective study
Mod Rheumatol. 2023 Aug 12:road083. doi: 10.1093/mr/road083. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37572107/ -
Lafay C, Assad Z, Ouldali N, Quoc EB, Clement A, Durand C, Fares S, Faye A, Eveillard LA, Kaguelidou F, Titah C, Valtuille Z, Vinit C, Meinzer U, Dumaine C.
Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis.
J Pediatr. 2023 Aug 21;263:113682. doi: 10.1016/j.jpeds.2023.113682. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37611738/ -
Ghadiri N, Injarie A.
Lights, camera, knowledge: Can patient education videos have a blockbuster impact in paediatric uveitis?
Eye (Lond). 2023 Aug 16. doi: 10.1038/s41433-023-02697-4. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37587375/
-
Maleki A, Patel PD, Foster CS.
Juvenile idiopathic arthritis and its associated uveitis.
Expert Rev Clin Immunol. 2023 Jul-Dec;19(9):1157-1169. doi: 10.1080/1744666X.2023.2231154. Epub 2023 Jul 4.
https://pubmed.ncbi.nlm.nih.gov/37401872/ -
Świerczyńska M, Tronina A, Filipek E.
Analysis of Peripapillary Retinal Nerve Fiber Layer Thickness in Acute Anterior Uveitis among Children with HLA-B27-Positive Juvenile Idiopathic Arthritis.
J Clin Med. 2023 Jul 22;12(14):4842. doi: 10.3390/jcm12144842.
https://pubmed.ncbi.nlm.nih.gov/37510957/
-
Vitale A, Casa FD, Guerriero S, Ragab G, Mauro A, Caggiano V, et al.
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry.
Ophthalmol Ther. 2023 May 11. doi: 10.1007/s40123-023-00712-1. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37166627/ -
Quartier P, Saadoun D, Belot A, Errera MH, Kaplanski G, Kodjikian L, et al.
French recommendations for the management of non-infectious chronic uveitis.
Rev Med Interne. 2023 May;44(5):227-252. doi: 10.1016/j.revmed.2023.04.002. Epub 2023 May 3.
https://pubmed.ncbi.nlm.nih.gov/37147233/ -
Maccora I, Land P, Miraldi Utz V, Angeles-Han ST.
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis.
Expert Rev Clin Immunol. 2023 May 11:1-4. doi: 10.1080/1744666X.2023.2207823. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37114341/ -
Martins A, Ganhão S, Oliveira Pinheiro F, Granjo Morais C, Rodrigues M, Leuzinger-Dias M, Figueira L, Brito I.
Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?
Reumatismo. 2023 May 8;75(1). doi: 10.4081/reumatismo.2023.1561.
https://pubmed.ncbi.nlm.nih.gov/37154253/ -
Sivakoti P, Swaminathan M, Magesan K, Pyare R, George AE, Ganesh SK, Biswas J, Dutta Majumder P.
Visual outcome in pediatric uveitis: A retrospective data review in 277 children.
Indian J Ophthalmol. 2023 May;71(5):2158-2161. doi: 10.4103/ijo.IJO_1993_22.
https://pubmed.ncbi.nlm.nih.gov/37203097/
-
van Straalen JW, Akay G, Kouwenberg CV, de Roock S, Kalinina Ayuso V, Wulffraat NM, de Boer J, Swart JF.
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis
RMD Open. 2023 Apr;9(2):e003010. doi: 10.1136/rmdopen-2023-003010.
https://pubmed.ncbi.nlm.nih.gov/37094979/ -
Maccora I, Land P, Miraldi Utz V, Angeles-Han ST.
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis.
Expert Rev Clin Immunol. 2023 Apr 28. doi: 10.1080/1744666X.2023.2207823. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/37114341/ -
Maccora I, Marrani E, Pagnini I, Mastrolia MV, de Libero C, Caputo R, Simonini G.
Challenges and management of childhood noninfectious chronic uveitis.
Expert Rev Clin Immunol. 2023 Apr 3:1-13. doi: 10.1080/1744666X.2023.2198210. Online ahead of print.PMID: 36996498
https://pubmed.ncbi.nlm.nih.gov/36996498/
-
Iannone C, Marelli L, Costi S, Pellico MR, La Franca L, Caporali R, Miserocchi E.
Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review.
Children (Basel). 2023 Feb 23;10(3):434. doi: 10.3390/children10030434.
https://pubmed.ncbi.nlm.nih.gov/36979992/ -
Rodier-Bonifas C, Rochet E, Seve P, Duquesne A, Nguyen AM, Denis P, et al.
Uveitis in children: Epidemiological, clinical and prognostic characteristics
J Fr Ophtalmol. 2023 Feb;46(2):163-172. doi: 10.1016/j.jfo.2022.08.005.
https://pubmed.ncbi.nlm.nih.gov/36642594/ -
Oliveira Pinheiro F, Leuzinger-Dias M, Fernandes BM, Fonseca D, Vilaça J, Figueira L, Brito I.
Outcome of Uveitis in Juvenile Idiopathic Arthritis and Spondyloarthritis Patients - A 5-Year Follow-Up Study.
ARP Rheumatol. 2023 Feb 26. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36842134/ -
Corredores J, Vofo B, Amer R.
Uveitis in Children: The Role of Biological Agents in Its Management.
Biomedicines. 2023 Feb 20;11(2):629. doi: 10.3390/biomedicines11020629.
https://pubmed.ncbi.nlm.nih.gov/36831165/ -
Alarfaj G, Alahmadi G, Alabdullah H, Al-Khars W, Al-Hammad F.
Pattern of Uveitis at a Tertiary Eye Hospital in Eastern Province of Saudi Arabia and Comparison with Local Literature.
Ocul Immunol Inflamm. 2023 Feb 6:1-5. doi: 10.1080/09273948.2022.2128822.
https://pubmed.ncbi.nlm.nih.gov/36745705/ -
van Meerwijk CLLI, Wieringa WG, de Boer JH, Jansonius NM, Los LI.
Factors Associated With Glaucoma Surgery in Pediatric Non-Infectious Uveitis
Ocul Immunol Inflamm. 2023 Feb 2:1-6. doi: 10.1080/09273948.2023.2166849.
https://pubmed.ncbi.nlm.nih.gov/36731522/
-
Markomichelakis NN, Aissopou EK, Chatzistefanou KI.
Pediatric Non-Infectious Uveitis: Long-Term Outcomes and Complications.
Ocul Immunol Inflamm. 2023 Jan 24:1-8. doi: 10.1080/09273948.2022.2162422. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36693268/
-
Kim BH, Chang IB, Lee S, Oh BL, Hong IH.
Incidence and Prevalence of Pediatric Noninfectious Uveitis in Korea: A Population-Based Study
J Korean Med Sci. 2022 Dec 19;37(49):e344. doi: 10.3346/jkms.2022.37.e344.
https://pubmed.ncbi.nlm.nih.gov/36536545/ - Leinonen S.
A Nordic screening guideline for juvenile idiopathic arthritis-related uveitisActa Ophthalmol. 2022 Dec 2. doi: 10.1111/aos.15299. Online ahead of print.
-
Bison HS, Janetos TM, Gao HM, Zhang DL, Song J, Bohnsack BL.
Comparison of Uveitis Incidence by Medication in Juvenile Idiopathic Arthritis and Implications for Screening.
Am J Ophthalmol. 2022 Nov 11;247:70-78. doi: 10.1016/j.ajo.2022.11.010. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36375593/ -
Angeles-Han ST, Srivastava SK.
Screening, Monitoring, and Treating Children with Juvenile Idiopathic Arthritis-Associated Uveitis: Visualizing Better Outcomes.
J Rheumatol. 2022 Nov 15:jrheum.221092. doi: 10.3899/jrheum.221092. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36379581/ -
Karaca I, Uludag G, Matsumiya W, Regenold J, Or C, Mobasserian A, Halim MS, Zaidi M, Lajevardi S, Dongchau A, Ghoraba H, Nguyen QD.
Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis.
Eye (Lond). 2022 Nov 28. doi: 10.1038/s41433-022-02315-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36443499/ -
Babel AT, Chin EK, Almeida DRP.
Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis.
Int Med Case Rep J. 2022 Nov 22;15:665-669. doi: 10.2147/IMCRJ.S384356.
https://pubmed.ncbi.nlm.nih.gov/36444172/ -
Guerriero S, Palmieri R, Craig F, La Torre F, Albano V, Alessio G, et al.
Psychological Effects and Quality of Life in Parents and Children with JIA-Associated Uveitis.
Children (Basel). 2022 Nov 30;9(12):1864. doi: 10.3390/children9121864.
https://pubmed.ncbi.nlm.nih.gov/36553308/
-
Berard R, Ng HY, Human A, Piskin D, Dhalla M, Gottlieb C, et al.
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
J Rheumatol. 2022 Oct 15:jrheum.220261. doi: 10.3899/jrheum.220261. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/36243417/
-
Shivpuri A, Turtsevich I, Solebo AL, Compeyrot-Lacassagne S.
Pediatric uveitis: Role of the pediatrician
Front Pediatr. 2022 Aug 1;10:874711. doi: 10.3389/fped.2022.874711. eCollection 2022.
https://pubmed.ncbi.nlm.nih.gov/35979409/ -
Van Straalen JW, Kearsley-Fleet L, Klotsche J, De Roock S, Minden K, Heiligenhaus A, et al; Paediatric Rheumatology International Trials Organisation (PRINTO), UK CAPS study and German ICON study.
Development and external validation of a model predicting new-onset chronic uveitis at different disease durations in juvenile idiopathic arthritis
Arthritis Rheumatol. 2022 Aug 23. doi: 10.1002/art.42329.
https://pubmed.ncbi.nlm.nih.gov/36054539/ -
McCracken C, Shantha JG, Yeh S, Jenkins K, Rouster-Stevens KA, Lambert SR, Prahalad S, Drews-Botsch C, Angeles-Han ST.
Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate
J Rheumatol. 2022 Aug 15:jrheum.220007. doi: 10.3899/jrheum.220007.
https://pubmed.ncbi.nlm.nih.gov/35970521/ -
Gaggiano C, Berlengiero V, Vitale A, Tarsia M, Grosso S, Tosi GM, Ricci F, Sota J, Caggiano V, Frediani B, Cantarini L, Cattalini M, Fabiani C.
The Role of Biologic Agents in the Management of Pediatric-Onset Noninfectious Posterior Scleritis
Ocul Immunol Inflamm. 2022 Aug 5:1-7. doi: 10.1080/09273948.2022.2106577.
https://pubmed.ncbi.nlm.nih.gov/35930360/ -
Paroli MP, Cappiello D, Staccini D, Caccavale R, Paroli M.
Tubulointerstitial Nephritis and Uveitis Syndrome (TINU): A Case Series in a Tertiary Care Uveitis Setting.
J Clin Med. 2022 Aug 25;11(17):4995. doi: 10.3390/jcm11174995.
https://pubmed.ncbi.nlm.nih.gov/36078924/
-
Skarin A, Berthold E, Rauer O, Bengtsson-Stigmar E.
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset.
Pediatr Rheumatol Online J. 2022 Jul 8;20(1):47. doi: 10.1186/s12969-022-00704-8. PMID: 35804416; PMCID: PMC9264563.
https://pubmed.ncbi.nlm.nih.gov/35804416/ -
Utz VM, Angeles-Han ST, Mwase N, Cassedy A, Hennard T, Lovell DJ, et al.
Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Non-Infectious, Chronic Anterior Uveitis.
Am J Ophthalmol. 2022 Jul 18:S0002-9394(22)00264-1. doi: 10.1016/j.ajo.2022.06.024. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35863492/ -
Alnahdi MA, Alkharashi M.
Ocular manifestations of COVID-19 in the pediatric age group.
Eur J Ophthalmol. 2022 Jul 27:11206721221116210. doi: 10.1177/11206721221116210. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35898182/
-
Li B, Yang L, Bai F, Tong B, Liu X.
Indications and effects of biological agents in the treatment of noninfectious uveitis.
Immunotherapy. 2022 Jun 13. doi: 10.2217/imt-2021-0303. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35695019/ -
Huynh E, Elhusseiny AM, Nihalani BR.
Paediatric anterior uveitis management in the USA: a single-centre, 10-year retrospective chart review exploring the efficacy and safety of systemic immunomodulatory therapy.
Eye (Lond). 2022 Jun 1. doi: 10.1038/s41433-022-02121-3. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35650322/
-
Foeldvari I, Maccora I, Petrushkin H, Rahman N, Anton J, de Boer J, Calzada-Hernández J, et al.
New and updated recommendations for the treatment of juvenile idiopathic arthritis associated uveitis and idiopathic chronic anterior uveitis.
Arthritis Care Res (Hoboken). 2022 May 31. doi: 10.1002/acr.24963. Epub ahead of print. PMID: 35638697.
https://pubmed.ncbi.nlm.nih.gov/35638697/ -
Kouwenberg CV, Wennink RAW, Shahabi M, Bozkir I, Ayuso VK, de Boer JH.
Clinical Course and Outcome in Pediatric Idiopathic Chronic Anterior Uveitis.
Am J Ophthalmol. 2022 May 2;241:198-205. doi: 10.1016/j.ajo.2022.04.015. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35513031/
-
Maccora I, Abu Rumeileh S, Curci F, de Libero C, Marrani E, Mastrolia MV, Pagnini I, Simonini.
Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience.
G.Front Pediatr. 2022 Apr 12;10:851453. doi: 10.3389/fped.2022.851453. eCollection 2022
https://pubmed.ncbi.nlm.nih.gov/35498797/ -
Paroli MP, Abbouda A, Albanese G, Accorinti M, Falcione A, Spadea L, Paroli M.
Persistence of Juvenile Idiopathic Arthritis-Associated Uveitis in Adulthood: A Retrospective Study.
J Clin Med. 2022 Apr 28;11(9):2471. doi: 10.3390/jcm11092471.
https://pubmed.ncbi.nlm.nih.gov/35566597/
-
Hwang DK, Hung JH, Chang YC, Chen CL, Chen SN, Cheng CK, et al.
Step-wise diagnostic approach for patients with uveitis - Experts consensus in Taiwan.
J Microbiol Immunol Infect. 2022 Mar 18:S1684-1182(22)00029-9. doi: 10.1016/j.jmii.2022.02.003. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35361552/ -
Eurelings LEM, Missotten TOAR, van Velthoven MEJ, van DaeLe PLA, van Laar JAM, van Hagen PM, Thiadens AAHJ, Rombach SM.
Long-term follow-up of patients with uveitis treated with adalimumab: response rates and reasons for discontinuation of therapy.
Am J Ophthalmol. 2022 Mar 18:S0002-9394(22)00108-8. doi: 10.1016/j.ajo.2022.03.017. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35314190/ -
Osswald D, Rameau AC, Terzic J, Sordet C, Bourcier T, Sauer A.
Risk Factors Leading to Anti-TNF Alpha Therapies in Pediatric Severe Uveitis.
Front Pediatr. 2022 Mar 4;10:802977. doi: 10.3389/fped.2022.802977.
https://pubmed.ncbi.nlm.nih.gov/35311049/ -
Zhong Z, Ding J, Su G, Liao W, Gao Y, Zhu Y, Deng Y, Li F, Du L, Gao Y, Yang P.
Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
Ophthalmology. 2022 Mar 18:S0161-6420(22)00209-3. doi: 10.1016/j.ophtha.2022.03.014. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35314268/
-
Maalouf G, Andrillon A, Leclercq M, Sève P, Bielefeld P, Gueudry J, Sené T, Titah C, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S, Thibault T, Chamieh CE, Cacoub P, Kodjikian L, Biard L, Bodaghi B, Saadoun D.
Lower relapses rate with infliximab versus adalimumab in sight threatening uveitis: a multicenter study of 330 patients.
Am J Ophthalmol. 2022 Feb 13:S0002-9394(22)00049-6. doi: 10.1016/j.ajo.2022.02.002.
https://pubmed.ncbi.nlm.nih.gov/35172172/ -
Tarsia M, Gaggiano C, Gessaroli E, Grosso S, Tosi GM, Frediani B, Cantarini L, Fabiani C.
Pediatric Scleritis: An Update.
Ocul Immunol Inflamm. 2022 Feb 28:1-10. doi: 10.1080/09273948.2021.2023582.
https://pubmed.ncbi.nlm.nih.gov/35226583/ -
Gaggiano C, Tarsia M, Tosi GM, Grosso S, Frediani B, Cantarini L, Fabiani C.
Adalimumab for refractory idiopathic scleritis in children.
Clin Exp Rheumatol. 2022 Feb 1. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/35238748/
-
Walscheid K, Rothaus K, Niewerth M, Klotsche J, Minden K, Heiligenhaus A.
Occurrence and risk factors of uveitis in juvenile psoriatic arthritis: Data from a population-based nationwide study in Germany.
J Rheumatol. 2022 Jan 15:jrheum.210755. doi: 10.3899/jrheum.210755.
https://pubmed.ncbi.nlm.nih.gov/35034000/ -
Samalia P, Sims J, Deva N.
Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis: Clinical Improvement with Infliximab.
Ocul Immunol Inflamm. 2022 Jan 26:1-8. doi: 10.1080/09273948.2022.2027466.
https://pubmed.ncbi.nlm.nih.gov/35081005/ -
Casa FD, Vitale A, Guerriero S, Sota J, Cimaz R, Ragab G, et al.
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis.
Ophthalmol Ther. 2022 Jan 31. doi: 10.1007/s40123-022-00459-1.
https://pubmed.ncbi.nlm.nih.gov/35099782/
-
Wen J, Hu H, Chen M, Yang H, Zhao Y, Liu Y.
Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review.
J Immunol Res. 2021 Dec 20;2021:2324400. doi: 10.1155/2021/2324400. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34966823/ -
Diala FJ, McCarthy K, Chen JL, Tsui E.
Multimodal imaging in pediatric uveitis.
Ther Adv Ophthalmol. 2021 Dec 6;13:25158414211059244. doi: 10.1177/25158414211059244. eCollection Jan-Dec 2021.
https://pubmed.ncbi.nlm.nih.gov/34901748/ -
Chevalier A, Duflos C, Clave S, Boyer O, Hogan J, Lahoche A et al.
Renal Prognosis in Children with Tubulointerstitial Nephritis and Uveitis Syndrome.
Kidney Int Rep. 2021 Oct 7;6(12):3045-3053. doi: 10.1016/j.ekir.2021.09.017. eCollection 2021 Dec.
https://pubmed.ncbi.nlm.nih.gov/34901573/
-
AlBloushi AF, Solebo AL, Gokhale E, Al-Hayouti H, Ajamil-Rodanes S, Petrushkin H.
Long Term Outcomes of Pediatric Idiopathic Intermediate Uveitis: Outcomes of Pediatric Intermediate Uveitis.
Am J Ophthalmol. 2021 Nov 12:S0002-9394(21)00584-5. doi: 10.1016/j.ajo.2021.11.003
https://pubmed.ncbi.nlm.nih.gov/34780797/ -
Chang MH, Shantha JG, Fondriest JJ, Lo MS, Angeles-Han ST.
Uveitis in Children and Adolescents.
Rheum Dis Clin North Am. 2021 Nov;47(4):619-641. doi: 10.1016/j.rdc.2021.07.005.
https://pubmed.ncbi.nlm.nih.gov/34635295/ -
Maccora I, Marrani E, Mastrolia MV, Abu-Rumeileh S, Maniscalco V, Fusco E, Barbati F, Pagnini I, Simonini G.
Ocular involvement in monogenic autoinflammatory disease.
Autoimmun Rev. 2021 Nov;20(11):102944. doi: 10.1016/j.autrev.2021.102944.
https://pubmed.ncbi.nlm.nih.gov/34509650/
-
Alafaleq M, Freund R, Penet MA, Fardeau C, Isnard-Bagnis C, Tezenas du Montcel S, et al.
Ciclosporin A in bilateral auto-immune chronic posterior uveitis associated with macular oedema: a Long-term Observational Safety and Efficacy Study.
Eye (Lond). 2021 Oct 30. doi: 10.1038/s41433-021-01829-y. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34718340/ -
Seepongphun U, Sittivarakul W, Dangboon W, Chotipanvithayakul R.
The Pattern of Uveitis in a Pediatric Population at a Tertiary Center in Thailand
Ocul Immunol Inflamm. 2021 Oct 22:1-9. doi: 10.1080/09273948.2021.1980814. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34686121/ -
Ramanan AV, Guly CM, Keller SY, Schlichting DE, de Bono S, Liao R, Quartier P.
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
Trials. 2021 Oct 9;22(1):689.doi: 10.1186/s13063-021-05651-5.
https://pubmed.ncbi.nlm.nih.gov/34627340/ -
Cooper AM, Flanagan ER, Ronis T, Goldberg B, Sherman AK, Smith C, Holland GN; CARRA Uveitis Workgroup.
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge.
Pediatr Rheumatol Online J. 2021 Oct 2;19(1):149. doi: 10.1186/s12969-021-00639-6.
https://pubmed.ncbi.nlm.nih.gov/34600529/
-
Molimard J, Pajot C, Olle P, Belot A, Quartier P, Uettwiller F, Couret C, Coste V, Costet C, Bodaghi B, Dureau P, Bailhache M, Pillet P.
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice.
Pediatr Rheumatol Online J. 2021 Sep 3;19(1):139. doi: 10.1186/s12969-021-00626-x.
https://pubmed.ncbi.nlm.nih.gov/34479590/ -
Tirelli F, Shafer BM, Davidson SL, Lerman MA.
Immunomodulation and TNF-alpha inhibition for tubulointerstitial nephritis and uveitis syndrome: a case series.
J AAPOS. 2021 Sep 29:S1091-8531(21)00536-X. doi: 10.1016/j.jaapos.2021.03.017. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34600106/ -
Xiong A, Liu D, Chen H, Yang G, Xiong C, Shuai Y, He L, Guo Z, Zhang L, Yang Y, Cui B, Shuai S.
The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies.
Front Pharmacol. 2021 Sep 16;12:620340. doi: 10.3389/fphar.2021.620340. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34603013/ -
Kouwenberg CV, Koopman-Kalinina Ayuso V, de Boer JH.
Clinical benefits and potential risks of adalimumab in non-JIA chronic paediatric uveitis.
Acta Ophthalmol. 2021 Sep 16. doi: 10.1111/aos.15012. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34532967/ -
Norcia LF, Kiappe OP, Jorge EC.
Biological Therapy in Noninfectious Pediatric Uveitis: A Systematic Review.
Clin Ophthalmol. 2021 Sep 7;15:3765-3776. doi: 10.2147/OPTH.S322445. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/34522080/
-
Sota J, Gentileschi S, Perfetti MO, Frediani B, Tosi GM, Cantarini L, Fabiani C.
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behcet's Syndrome.
Ophthalmol Ther. 2021 Aug 30. doi: 10.1007/s40123-021-00387-6. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34458968/ -
Lanz S, Seidel G, Skrabl-Baumgartner A
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab.
Pediatr Rheumatol Online J. 2021 Aug 21;19(1):132. doi: 10.1186/s12969-021-00630-1.
https://pubmed.ncbi.nlm.nih.gov/34419092/
-
Sözeri B, Kardeş E, Salı E, Çakır D, Demir F.
Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis.
Clin Exp Rheumatol. 2021 Jul-Aug;39(4):907-912. Epub 2021 Feb 9. PMID: 33635217.
https://pubmed.ncbi.nlm.nih.gov/33635217/ -
Wennink RAW, de Boer JH, Hiddingh S, Haasnoot AJW, Kalinina Ayuso V, de Hoop T, van Setten J, Spierings E, Kuiper JJW.
Next-Generation HLA Sequence Analysis Uncovers Shared Risk Alleles Between Clinically Distinct Forms of Childhood Uveitis.
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):19. doi: 10.1167/iovs.62.9.19.
https://pubmed.ncbi.nlm.nih.gov/34254975/ -
Heaney A, McLoone E, Williams M, Silvestri G, Courtney AE, O'Rourke D, McAvoy CE.
Tubulointerstitial nephritis and uveitis in Northern Ireland.
Eye (Lond). 2021 Jul 29. doi: 10.1038/s41433-021-01677-w. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34326494/
-
Joanne Thomas, Sanjana Kuthyar, Jessica G Shantha, Sheila T Angeles-Han, Steven Yeh.
Update on biologic therapies for juvenile idiopathic arthritis-associated uveítis.
Ann Eye Sci. 2021 Jun;6:19. doi: 10.21037/aes-2019-dmu-10. Epub 2021 Jun 15.
https://pubmed.ncbi.nlm.nih.gov/34131629/ -
Elena Bolletta, Marco Coassin, Danilo Iannetta et al.
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
J Clin Med. 2021 May 31;10(11):2437. doi: 10.3390/jcm10112437.
https://pubmed.ncbi.nlm.nih.gov/34072679/ -
Quartier P.
Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches.
J Clin Med. 2021 Jun 30;10(13):2934. doi: 10.3390/jcm10132934.
https://pubmed.ncbi.nlm.nih.gov/34208973/
-
Bolletta E, Coassin M, Iannetta D, et al.
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
J Clin Med. 2021;10(11):2437. Published 2021 May 31. doi:10.3390/jcm10112437
https://pubmed.ncbi.nlm.nih.gov/34072679/
-
Shin Y, Kang JM, Lee J, Lee CS, Lee SC, Ahn JG.
Epidemiology of pediatric uveitis and associated systemic diseases.
Pediatr Rheumatol Online J. 2021 Apr 1;19(1):48.
https://pubmed.ncbi.nlm.nih.gov/33794945/ -
Wong Chung JERE, Engin Ö, Wolfs TFW, Renson TJC, de Boer JH.
Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
Lancet. 2021 Apr 3;397(10281):e10. doi: 10.1016/S0140-6736(21)00579-1
https://pubmed.ncbi.nlm.nih.gov/33812491/
-
Papasavvas I, Herbort CP Jr.
Granulomatous Features in Juvenile Idiopathic Arthritis-Associated Uveitis is Not a Rare Occurrence.
Clin Ophthalmol. 2021 Mar 8;15:1055-1059. doi: 10.2147/OPTH.S299436.
https://pubmed.ncbi.nlm.nih.gov/33727787/ -
Miserocchi E, Giuffre C, Caporali R, Favalli EG.
Secukinumab in HLA-B27 associated uveitis.
Clin Exp Ophthalmol. 2021 Mar 20. doi: 10.1111/ceo.13922. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33742762/ -
Sota J, Gentileschi S, Vitale A, Gaggiano C, De Bartolo G, Bianco MT, et al.
Effectiveness of SB5, an Adalimumab Biosimilar, in Patients With Noninfectious Uveitis: A Real-Life Monocentric Experience.
Asia Pac J Ophthalmol (Phila). 2021 Mar 19. doi: 10.1097/APO.0000000000000380. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33756492/ -
Li Y, Mao X, Tang X, Mao H.
Efficacy and Safety of Anti-TNFalpha Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis.
Rheumatol Ther. 2021 Mar 15. doi: 10.1007/s40744-021-00296-x.
https://pubmed.ncbi.nlm.nih.gov/33721267/ -
Nguyen AH, Mekonnen B, Kim E, Acharya NR.
Clinical outcomes of pediatric macular edema associated with non-infectious uveitis.
J Ophthalmic Inflamm Infect. 2021 Mar 15;11(1):8. doi: 10.1186/s12348-021-00236-4
https://pubmed.ncbi.nlm.nih.gov/33718975/
-
Esen E, Sizmaz S, Balci S, Ekinci RMK, Demircan N.
Clinical features of childhood uveitis at a tertiary referral center in Southern Turkey.
Int Ophthalmol. 2021 Feb 24. doi: 10.1007/s10792-021-01764-7.
https://pubmed.ncbi.nlm.nih.gov/33624176/ -
Sözeri B, Kardeş E, Salı E, Çakır D, Demir F.
Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis.
Clin Exp Rheumatol. 2021 Feb 9.
https://pubmed.ncbi.nlm.nih.gov/33635217/ -
Sobolewska B, Baglivo E, Edwards AO, Kramer M, Miserocchi E, Palestine AG, Schwab IR, Zamir E, Doycheva D, Zierhut M.
Drug-induced Sarcoid Uveitis with Biologics.
Ocul Immunol Inflamm. 2021 Feb 17:1-8. doi: 10.1080/09273948.2020.1850799.
https://pubmed.ncbi.nlm.nih.gov/33596386/ -
Ansari AS, Amir Z, Williams GS.
Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies.
Ophthalmol Ther. 2021 Mar;10(1):193-200. doi: 10.1007/s40123-020-00328-9. Epub 2021 Jan 19.
https://pubmed.ncbi.nlm.nih.gov/33464558/ -
Maccora I, Fusco E, Marrani E, Ramanan AV, Simonini G.
Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis.
Rheumatology (Oxford). 2021 Feb 1;60(2):568-587. doi: 10.1093/rheumatology/keaa595.
https://pubmed.ncbi.nlm.nih.gov/33219694/ -
Akbarali S, Rahi JS, Dick AD, Parkash K, Etherton K, Edelsten C, Liu X, Solebo AL.
Imaging-Based Uveitis Surveillance in Juvenile Idiopathic Arthritis: Feasibility, Acceptability, and Diagnostic Performance.
Arthritis Rheumatol. 2021 Feb;73(2):330-335. doi: 10.1002/art.41530. Epub 2020 Dec 24.
https://pubmed.ncbi.nlm.nih.gov/32976696/
-
Smith JR, Matthews JM, Conrad D, Hall AJ, Niederer RL, Singh-Grewal D, Tay-Kearney ML, Wells JM, Zagora SL; Australian and New Zealand Juvenile Idiopathic Arthritis-Uveitis Working Group, McCluskey PJ.
Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis.
Clin Exp Ophthalmol. 2021 Jan 10. doi: 10.1111/ceo.13856. Epub ahead of print. PMID: 33426782.
https://pubmed.ncbi.nlm.nih.gov/33426782/ -
Wakefield D, Clarke D, McCluskey P.
Recent Developments in HLA B27 Anterior Uveitis.
Front Immunol. 2021 Jan 5;11:608134. doi: 10.3389/fimmu.2020.608134. PMID: 33469457; PMCID: PMC7813675.
https://pubmed.ncbi.nlm.nih.gov/33469457/
-
van Straalen JW, Giancane G, Amazrhar Y, Tzaribachev N, Lazar C, Uziel Y, Telcharova-Mihaylovska A, Len CA, Miniaci A, Boteanu AL, Filocamo G, Mastri MV, Arkachaisri T, Magnolia MG, Hoppenreijs E, de Roock S, Wulffraat NM, Ruperto N, Swart JF.
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis.
Rheumatology (Oxford). 2020 Dec 4:keaa733. doi: 10.1093/rheumatology/keaa733
https://pubmed.ncbi.nlm.nih.gov/33274366/ -
Tripathy K, Ying H, Maldonado Cerda A, Filipowicz A, Kaya M, Seymen Z, Anesi SD, Chang PY, Foster CS.
Widefield Fundus Fluorescein Angiography Features of Uveitis Associated with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2020 Dec 2:1-10
https://pubmed.ncbi.nlm.nih.gov/33264037/ -
Petty RE, Zheng Q.
Uveitis in juvenile idiopathic arthritis.
World J Pediatr. 2020 Dec;16(6):562-565
https://pubmed.ncbi.nlm.nih.gov/31965444/
- Rahman N, Petrushkin H, Solebo AL.
Paediatric autoimmune and autoinflammatory conditions associated with uveitis.
Ther Adv Ophthalmol. 2020 Nov 2;12:2515841420966451
https://pubmed.ncbi.nlm.nih.gov/33225212/ - Maccora I, Fusco E, Marrani E, Ramanan AV, Simonini G.
Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis.
Rheumatology (Oxford). 2020 Nov 21:keaa595. doi: 10.1093/rheumatology/keaa595
https://pubmed.ncbi.nlm.nih.gov/33219694/ - Koay SY, Johnson M, Xing W, Foot B, MacEwen C, Dahlmann-Noor A, Thomas D.
Childhood uveitis not associated with juvenile idiopathic arthritis: a national survey of incidence, management and visual outcomes.
Eye (Lond). 2020 Nov 16. DOI:10.1038/s41433-020-01267-2
https://pubmed.ncbi.nlm.nih.gov/33199865/
-
Cassedy A, Altaye M, Andringa J, Cooper AM, Drews-Botsch C, Engelhard G Jr, Hennard T, Holland GN, Jenkins K, Lambert SR, Lipscomb J, McCracken C, McCurdy DK, McDonald J, Mwase N, Prahalad S, Stahl E, Miraldi Utz V, Walker AA, Yeh S, Angeles-Han ST.
Assessing the validity and reliability of the Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) questionnaire among children with uveitis.
Arthritis Care Res (Hoboken). 2020 Oct 21. doi: 10.1002/acr.24491. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/33085849/
-
Akbarali S, Rahi JS, Dick AD, Parkash K, Etherton K, Edelsten C, Liu X, Solebo AL.
Imaging based uveitis surveillance in juvenile idiopathic arthritis: feasibility, acceptability and diagnostic performance.
Arthritis Rheumatol. 2020 Sep 25. doi: 10.1002/art.41530. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32976696/ -
Marino A, Weiss PF, Brandon TG, Lerman MA.
Juvenile Spondyloarthritis: focus on uveitis
Pediatr Rheumatol Online J. 2020 Sep 10;18(1):70. doi: 10.1186/s12969-020-00463-4
https://pubmed.ncbi.nlm.nih.gov/32912296/ -
Miserocchi E, Giuffrè C, Modorati GM, Cimaz R.
Management of Juvenile Idiopathic Arthritis-associated Uveitis during the COVID-19 Pandemic in a Pediatric Referral Center in Lombardy
Ocul Immunol Inflamm. 2020 Sep 25:1-3. doi: 10.1080/09273948.2020.1800752. Online ahead of print
https://pubmed.ncbi.nlm.nih.gov/32976038/ -
Takase H, Acharya NR, Babu K, Bodaghi B, Khairallah M, McCluskey PJ, Tesavibul N, Thorne JE, Tugal-Tutkun I, Yamamoto JH, Rao NA, Smith JR, Mochizuki M; 7th IWOS Study Group.
Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis.
Br J Ophthalmol. 2020 Sep 15:bjophthalmol-2020-317354. doi: 10.1136/bjophthalmol-2020-317354. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32933934/ -
Rosenbaum JT, Harrington CA, Searles RP, Fei SS, Zaki A, Arepalli S, Paley MA, Hassman LM, Vitale AT, Conrady CD, Keath P, Mitchell C, Watson L, Planck SR, Martin TM, Choi D.
Revising the diagnosis of idiopathic uveitis by peripheral blood transcriptomics.
Am J Ophthalmol. 2020 Sep 14:S0002-9394(20)30505-5. doi: 10.1016/j.ajo.2020.09.012. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32941857/ -
Sadhu S, Dutta Majumder P, Biswas J.
Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India.
Indian J Ophthalmol. 2020 Sep;68(9):1929-1933. doi: 10.4103/ijo.IJO_966_20.
https://pubmed.ncbi.nlm.nih.gov/32823417/
-
Maccora I, Sen ES, Ramanan AV.
Update on noninfectious uveitis in children and its treatment
Curr Opin Rheumatol . 2020 Sep;32(5):395-402. doi:
10.1097/BOR.0000000000000723.
https://pubmed.ncbi.nlm.nih.gov/32675714/ -
Rypdal V, Glerup M, Songstad NT, Bertelsen G, Christoffersen T, Arnstad ED, Aalto K, Berntson L, Fasth A, Herlin T, Ekelund M, Peltoniemi S, Toftedal P, Nielsen S, Leinonen S, Bangsgaard R, Nielsen R, Rygg M, Nordal E; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Uveitis in Juvenile Idiopathic Arthritis: 18-year Outcome in the Population-based Nordic Cohort Study.
Ophthalmology. 2020 Aug 28:S0161-6420(20)30842-3. doi: 10.1016/j.ophtha.2020.08.024.
https://pubmed.ncbi.nlm.nih.gov/32866542/ -
Hassan WA, Medhat BM, Youssef MM, Farag Y, Mostafa N, Alnaggar AR, Behiry ME, Abdel Noor RA, Allam RSHM.
Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study.
Clin Rheumatol. 2020 Sep 2. doi: 10.1007/s10067-020-05362-3.
https://pubmed.ncbi.nlm.nih.gov/32876781/ -
Choe S, Heo JW, Oh BL.
Quiescence and Subsequent Anterior Chamber Inflammation in Adalimumab-treated Pediatric Noninfectious Uveitis
Korean J Ophthalmol. 2020 Aug;34(4):274-280. doi: 10.3341/kjo.2020.0005.
https://pubmed.ncbi.nlm.nih.gov/32783419/ -
Turk M, Hayworth J, Nevskaya T, Pope J.
The frequency of uveitis in patients with adult versus childhood spondyloarthritis.
RMD Open. 2020 Aug;6(2):e001196. doi: 10.1136/rmdopen-2020-001196.PMID: 32868451
https://pubmed.ncbi.nlm.nih.gov/32868451/ -
Orès R, Terrada C, Errera MH, Thorne JE, Doukhan R, Cassoux N, Penaud B, LeHoang P, Quartier PM, Bodaghi B.
Laser Flare Photometry: A Useful Tool for Monitoring Patients with Juvenile Idiopathic Arthritis-associated Uveitis.
Ocul Immunol Inflamm. 2020 Aug 24:1-11. doi: 10.1080/09273948.2020.1792511.
https://pubmed.ncbi.nlm.nih.gov/32835572/
-
Maccora I, Sen ES, Ramanan AV.
Update on noninfectious uveitis in children and its treatment.
Curr Opin Rheumatol. 2020 Jul 15. doi: 10.1097/BOR.0000000000000723. Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32675714/
-
Siiskonen M, Hirn I, Pesälä R, Hautala T, Ohtonen P, Hautala N.
Prevalence, incidence and epidemiology of childhood uveitis.
Acta Ophthalmol. 2020 Jun 26. doi: 10.1111/aos.14535. PMID: 32588987
https://pubmed.ncbi.nlm.nih.gov/32588987/ -
Fung SSM, El Hamouly A, Sami H, Jiandani D, Williams S, Tehrani N, Mireskandari K, Ali A.
Corneal endothelium in paediatric patients with uveitis: a prospective longitudinal study.
Br J Ophthalmol. 2020 Jun 10:bjophthalmol-2020-316120.
https://pubmed.ncbi.nlm.nih.gov/32522794/ -
Silvestri E, Bitossi A, Bettiol A, Emmi G, Urban ML, Mattioli I, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Prisco D.
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome.
Inflammopharmacology. 2020 Jun;28(3):711-718. doi: 10.1007/s10787-020-00697-4.
https://pubmed.ncbi.nlm.nih.gov/32157555/ -
Sobrin L, Pistilli M, Dreger K, Kothari S, Khachatryan N, Artornsombudh P, Pujari SS, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group.
Factors Predictive of Remission of Chronic Anterior Uveitis.
Ophthalmology. 2020 Jun;127(6):826-834. doi: 10.1016/j.ophtha.2019.11.020.
https://pubmed.ncbi.nlm.nih.gov/31932091/ -
Çakar Özdal P.
Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
Turk J Ophthalmol. 2020 Jun 27;50(3):169-182. doi: 10.4274/tjo.galenos.2019.60308
https://pubmed.ncbi.nlm.nih.gov/32631005/
- Stewart DJ, Sekar T, Tullus K.
A rare case of tubulointerstitial nephritis and uveitis (TINU) syndrome: Questions.
Pediatr Nephrol. 2020 May 21.
https://doi.org/10.1007/s00467-020-04582-8 - Leinonen S, Kotaniemi KM, Kivelä TT, Krootila K
Results 5 to 10 years after cataract surgery with primary IOL implantation in juvenile idiopathic arthritis-related uveitis.
J Cataract Refract Surg. 2020 Apr 24. doi: 10.1097/j.jcrs.0000000000000222. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32341296 - Navarrete A, Koriat A, Amer R.
Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children
Graefes Arch Clin Exp Ophthalmol. 2020 Apr 28. doi: 10.1007/s00417-020-04696-7. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/32346784
- Miserocchi E, Giuffrè C, Cornalba M, Pontikaki I, Cimaz R.
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
Clin Rheumatol. 2020 Mar;39(3):847-851.
https://www.ncbi.nlm.nih.gov/pubmed/31897953 - Carpentier SJ, Jung JL, Patnaik JL, Pecen PE, Palestine AG.
A Cross-Sectional Online Survey Identifies Subspecialty Differences in the Management of Pediatric Cataracts Associated with Uveitis.
Ophthalmol Ther. 2020 Mar 10. doi: 10.1007/s40123-020-00245-x. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32157612 - Walscheid K, Glandorf K, Rothaus K, Niewerth M, Klotsche J, Minden K, Heiligenhaus A.
Enthesitis-related arthritis: prevalence and complications of associated uveitis in children and adolescents from a population-based nation-wide study in Germany.
J Rheumatol. 2020 Mar 15. pii: jrheum.191085. doi: 10.3899/jrheum.191085. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32173656 - Silvestri E, Bitossi A, Bettiol A, Emmi G, Urban ML, Mattioli I, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Prisco D
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome.
Inflammopharmacology. 2020 Mar 10. doi: 10.1007/s10787-020-00697-4. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32157555
- Schnabel A, Unger E, Brück N, Berner R, Range U, Holl-Wieden A, Morbach H, Leszczynska A, Bau V, Hedrich CM.
High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysis.
Clin Immunol. 2020 Feb;211:108327. doi: 10.1016/j.clim.2019.108327. Epub 2019 Dec 18.
https://www.ncbi.nlm.nih.gov/pubmed/31863906 - Walscheid K, Klotsche J, Tappeiner C, Niewerth M, Foell D, Minden K, Heiligenhaus A.
Adherence to ophthalmological screening recommendations and course of uveitis in children with juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study.
Clin Exp Rheumatol. 2020 Feb 19.
https://www.ncbi.nlm.nih.gov/pubmed/32105591 - Wennink RAW, Ayuso VK, de Vries LA, Vastert SJ, de Boer JH.
Tocilizumab as an Effective Treatment Option in Children with Refractory Intermediate and Panuveitis.
Ocul Immunol Inflamm. 2020 Feb 14:1-5. doi: 10.1080/09273948.2020.1712431.
https://www.ncbi.nlm.nih.gov/pubmed/32058831 - Jari M, Shiari R, Salehpour O, Rahmani K.
Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis.
Orphanet J Rare Dis. 2020 Feb 4;15(1):41. doi: 10.1186/s13023-020-1324-x.
https://www.ncbi.nlm.nih.gov/pubmed/32019589 - Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L.
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.
Clin Rheumatol. 2020 Feb;39(2):327-337. doi: 10.1007/s10067-019-04763-3. Epub 2019 Dec 10.
https://www.ncbi.nlm.nih.gov/pubmed/31823144 - Sestan M, Grguric D, Sedmak M, Frkovic M, Kifer N, Grubic M, Peric S, Vukojevic N, Potocki K, Jelusic M.
Quality of life in children suffering from juvenile idiopathic arthritis-associated uveitis.
Rheumatol Int. 2020 Feb 22. doi: 10.1007/s00296-020-04536-1.
https://www.ncbi.nlm.nih.gov/pubmed/32088753 - Abraham A, Saboo US, Ducca BL, Lawand AT, Ronconi C, Cao JH.
The Detection of Occult Retinal Vasculitis on Fluorescein Angiography in Pediatric Uveitis.
Ophthalmol Retina. 2020 Feb;4(2):198-203. doi: 10.1016/j.oret.2019.09.007. Epub 2019 Sep 20.
https://www.ncbi.nlm.nih.gov/pubmed/31708487
- Miserocchi E, Giuffrè C, Cornalba M, Pontikaki I, Cimaz R.
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
Clin Rheumatol. 2020 Jan 2. doi: 10.1007/s10067-019-04875-w. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31897953
- Schnabel A, Unger E, Brück N, Berner R, Range U, Holl-Wieden A, Morbach H, Leszczynska A, Bau V, Hedrich CM.
High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysis.
Clin Immunol. 2019 Dec 18;211:108327.
https://www.ncbi.nlm.nih.gov/pubmed/31863906 - Sen ES, Ramanan AV.
Juvenile idiopathic arthritis-associated uveitis.
Clin Immunol. 2019 Dec 9;211:108322. doi: 10.1016/j.clim.2019.108322.
https://www.ncbi.nlm.nih.gov/pubmed/31830532 - Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L.
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.
Clin Rheumatol. 2019 Dec 10. doi: 10.1007/s10067-019-04763-3
https://www.ncbi.nlm.nih.gov/pubmed/31823144 - Miserocchi E, Giuffrè C, Cicinelli MV, Marchese A, Gattinara M, Modorati G, Bandello F.
Oral phospholipidic curcumin in juvenile idiopathic arthritis-associated uveitis.
Eur J Ophthalmol. 2019 Dec 4:1120672119892804. doi: 10.1177/1120672119892804.
https://www.ncbi.nlm.nih.gov/pubmed/31801359 - Miyazawa H, Fujita Y, Muramatsu K, Iwata H, Nomura T, Namba K, Hoshina D, Shimizu H.
Refractory juvenile psoriatic uveitis without arthritis: a literature review.
J Eur Acad Dermatol Venereol. 2019 Dec 2. doi: 10.1111/jdv.16127
https://www.ncbi.nlm.nih.gov/pubmed/31793073
- Adán A, Moll-Udina A, Ramirez J, Llorenç V.
Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report.
Ocul Immunol Inflamm. 2019 Oct 7:1-3. doi: 10.1080/09273948.2019.1644350. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31589540 - Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, de Vicuna CG, Zilhao C, Yeh S, Anton J
Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
Pediatr Rheumatol Online J. 2019 Oct 1;17(1):66. doi: 10.1186/s12969-019-0345-2.
https://www.ncbi.nlm.nih.gov/pubmed/31575380 - Davies R, Cock D, Kearsley-Fleet L, Southwood T, Baildam E, Beresford MW, Foster HE, Thomson W, Ramanan A, Hyrich KL; British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN) and the Biologics for Children with Rheumatic Diseases (BCRD) study.
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
Rheumatology (Oxford). 2019 Oct 12. pii: kez449. doi: 10.1093/rheumatology/kez449. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31605484 - Cheung CSY, Mireskandari K, Ali A, Silverman E, Tehrani N.
Earlier use of systemic immunosuppression is associated with fewer ophthalmic surgeries in paediatric non-infectious uveitis
Br J Ophthalmol. 2019 Oct 11. pii: bjophthalmol-2019-314875. doi: 10.1136/bjophthalmol-2019-314875. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31604701
- Busch M, Wefelmeyer KL, Walscheid K, Rothaus K, Bauer D, Deeg CA, Degroote RL,
Identification of Ocular Autoantigens Associated With Juvenile Idiopathic Arthritis-Associated Uveitis.
Ackermann D, König S, Thanos S, Kasper M, Heiligenhaus A.
Front Immunol. 2019 Aug 6;10:1793.
https://www.ncbi.nlm.nih.gov/pubmed/31447836 - Reiff A.
Clinical Presentation, Management and Long Term Outcome of Pars Planitis (PP), Panuveitis (PU) and Vogt-Koyanagi-Harada disease (VKH) in Children and Adolescents.
Arthritis Care Res (Hoboken). 2019 Aug 23.
https://www.ncbi.nlm.nih.gov/pubmed/31444859
- Bauermann P, Heiligenhaus A, Heinz C.
Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2019 Jul 3:1-3. doi: 10.1080/09273948.2019.1605453. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31268748 - Mastrangelo G, Foeldvari I, Anton J, Simonini G.
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?
Pediatr Rheumatol Online J. 2019 Jul 11;17(1):40.
https://www.ncbi.nlm.nih.gov/pubmed/31296236
- Marino A, Weiss PF, Davidson SL, Lerman MA.
Symptoms in noninfectious uveitis in a pediatric cohort: initial presentation versus recurrences.
J AAPOS. 2019 Jun 26. pii: S1091-8531(19)30146-6
https://www.ncbi.nlm.nih.gov/pubmed/31254672 - Hayworth JL, Turk MA, Nevskaya T, Pope JE.
The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases.
Joint Bone Spine. 2019 Jun 14. pii: S1297-319X(19)30092-2. doi: 10.1016/j.jbspin.2019.06.001
https://www.ncbi.nlm.nih.gov/pubmed/31207292 - Horton S, Jones AP, Guly CM, Hardwick B, Beresford MW, Lee RWJ, Dick AD, Ramanan AV.
Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.
Am J Ophthalmol. 2019 Jun 12. pii: S0002-9394(19)30274-0. doi: 10.1016/j.ajo.2019.06.007. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31201796
- Alba-Linero C, Sala-Puigdollers A, Romero B, Llorenç V, Adan A, Zarranz-Ventura J.
Long-Term Intravitreal Dexamethasone Implant Outcomes in Uveitis.
Ocul Immunol Inflamm. 2019 Apr 17:1-10. doi: 10.1080/09273948.2019.1578380. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30994370 - Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Arthritis Care Res (Hoboken). 2019 Apr 25. doi: 10.1002/acr.23871
https://www.ncbi.nlm.nih.gov/pubmed/31021540 - Ramanan AV, Dick AD, Jones AP, Hughes DA, McKay A, Rosala-Hallas A, Williamson PR, Hardwick B, Hickey H, Rainford N, Hickey G, Kolamunnage-Dona R, Culeddu G, Plumpton C, Wood E, Compeyrot-Lacassagne S, Woo P, Edelsten C, Beresford MW.
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
Health Technol Assess. 2019 Apr;23(15):1-140. doi: 10.3310/hta23150.
https://www.ncbi.nlm.nih.gov/pubmed/31033434 - Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.
Clin Exp Rheumatol. 2019 Apr 3. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30943133
- Haasnoot AJW, Kuiper JJW, de Boer JH.
Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice.
Expert Rev Clin Immunol. 2019 Mar 15:1-10. doi: 10.1080/1744666X.2019.1593139. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30874452 - Touhami S, Diwo E, Sève P, Trad S, Bielefeld P, Sène D, Abad S, Brézin A, Quartier P, Koné Paut I, Weber M, Chiquet C, Errera MH, Sellam J, Cacoub P, Kaplanski G, Kodjikian L, Bodaghi B, Saadoun D.
Expert opinion on the use of biological therapy in non-infectious uveitis.
Expert Opin Biol Ther. 2019 Mar 19:1-14. doi: 10.1080/14712598.2019.1595578. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30888881 - Wildschütz L, Ackermann D, Witten A, Kasper M, Busch M, Glander S, Melkonyan H, Walscheid K, Tappeiner C, Thanos S, Barysenka A, Koch J, Heinz C, Laffer B, Bauer D, Stoll M, König S, Heiligenhaus A.
Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis.
J Autoimmun. 2019 Mar 15. pii: S0896-8411(19)30038-1. doi: 10.1016/j.jaut.2019.03.004. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30885419 - DeSouza PJ, Shah R.
Characterization of Blau syndrome panuveitis with wide-field fluorescein angiography.
Am J Ophthalmol Case Rep. 2019 Mar 29;14:92-94. doi: 10.1016/j.ajoc.2019.03.006.
https://www.ncbi.nlm.nih.gov/pubmed/30989150 - Oh LJ, Nguyen CL, Phan K, Wong E, Zagora S, Singh-Grewal D, Chaitow J, Grigg JR, McCluskey P.
Changing biological disease modifying treatment for paediatric uveitis in the real world.
Clin Exp Ophthalmol. 2019 Mar 4. doi: 10.1111/ceo.13494. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30834650
- Dipasquale V, Atteritano M, Fresta J, Castagna I, Conti G.
Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases.
J Clin Pharm Ther. 2019 Feb 27. doi: 10.1111/jcpt.12821. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30815892 - Wu S, Zhong L, Sun Z, Zhu T, Song H, Sui R.
Ocular Features in Chinese Patients with Blau Syndrome.
Ocul Immunol Inflamm. 2019 Feb 26:1-7. doi: 10.1080/09273948.2019.1569239. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30806112 - Eiger-Moscovich M, Tomkins-Netzer O, Amer R, Habot-Wilner Z, Kasb A, Friling R, Kramer M.
Visual and Clinical Outcome of Macular Edema Complicating Pediatric Noninfectious Uveitis.
Am J Ophthalmol. 2019 Feb 14. pii: S0002-9394(19)30063-7. doi: 10.1016/j.ajo.2019.02.011. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30772346
- Vegas-Revenga N, Calvo-Río V, Mesquida M, Adán A, Hernández MV, Beltrán E, Pascual EV, Díaz-Valle D, Cordovés GD, Hernandez-Garfella M, Martínez-Costa L, Calvo I, Atanes A, Linares LF, Modesto C, González-Vela C, Demetrio-Pablo R, Aurrecoechea E, Cordero M, Domínguez-Casas LC, Atienza-Mateo B, Martín-Varillas JL, Loricera J, Palmou-Fontana N, Hernández JL, González-Gay MA, Blanco R.
Anti-il6-r tocilizumab in refractory and non-infectious uveitic cystoid macular edema. Multicenter study of 25 patients.
Am J Ophthalmol. 2019 Jan 17. pii: S0002-9394(19)30003-0. doi: 10.1016/j.ajo.2018.12.019. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30660771
- Heiligenhaus A, Minden K, Tappeiner C, Baus H, Bertram B, Deuter C, Foeldvari I, Föll D, Frosch M, Ganser G, Gaubitz M, Günther A, Heinz C, Horneff G, Huemer C, Kopp I, Lommatzsch C, Lutz T, Michels H, Neß T, Neudorf U, Pleyer U, Schneider M, Schulze-Koops H, Thurau S, Zierhut M, Lehmann HW.
Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.
Semin Arthritis Rheum. 2018 Dec 4. pii: S0049-0172(18)30462-1. doi: 10.1016/j.semarthrit.2018.11.004. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30595409 - Heiligenhaus A, Klotsche J, Tappeiner C, Sengler C, Niewerth M, Liedmann I, Hoeft S, Walscheid K, Lavric M, Foell D, Minden K.
Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
Rheumatology (Oxford). 2018 Dec 26. doi: 10.1093/rheumatology/key406. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30590748
- Ito T, Hoshina T, Mizuki K, Fukuda 1, Ishibashi S, Kusuhara K
A pediatric case with parvovirus B19-associated uveitis without autoantibody formation.
Nagoya J Med Sci. 2018 Nov;80(4):611-614. doi: 10.18999/nagjms.80.4.611
https://www.ncbi.nlm.nih.gov/pubmed/30587876 - McCracken C, Yeh S, Jenkins K, Travers C, Stryker D, Tommasello S, Rouster-Stevens KA, Lambert SR, Prahalad S, Drews-Botsch C, Angeles-Han ST
Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis.
Eye (Lond). 2018 Nov 28. doi: 10.1038/s41433-018-0283-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30487588
- Hughes DA, Culeddu G, Plumpton C, Wood E, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot Lacassagne S, Hardwick B, Hickey H, Woo P, Beresford MW, Ramanan AV.
Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis
Ophthalmology. 2018 Oct 15. pii: S0161-6420(18)31146-1. doi: 10.1016/j.ophtha.2018.09.043. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30336181 - Lee JJY, Duffy CM, Guzman J, Oen K, Barrowman N, Rosenberg AM, Shiff NJ, Boire G, Stringer E, Spiegel L, Morishita KA, Lang B, Reddy D, Huber AM, Cabral DA, Feldman BM, Yeung RSM, Tucker LB, Watanabe Duffy K; ReACCh-Out Investigators.
Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.
Arthritis Care Res (Hoboken). 2018 Oct 15. doi: 10.1002/acr.23783. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30320957 - Hissink Muller P, Brinkman DMC, Schonenberg-Meinema D, van den Bosch WB, Koopman-Keemink Y, Brederije ICJ, Bekkering PW, Kuijpers TW, Van Rossum M, van Suijlekom-Smit LW, van den Berg JM, Boehringer S, Allaart CF, Ten Cate R.
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial
Ann Rheum Dis. 2018 Oct 11. pii: annrheumdis-2018-213902. doi: 10.1136/annrheumdis-2018-213902. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30309970 - Wieringa WG, Armbrust W, Legger GE, Los LI.
Efficacy of High-Dose Methotrexate in Pediatric Non-Infectious Uveitis
Ocul Immunol Inflamm. 2018 Oct 22:1-9. doi: 10.1080/09273948.2018.1529800. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30346845
- Zygmunt A, Lipińska J, Biernacka-Zielińska M, Lipiec E, Niwald A, Smolewska E
Comparison of uveitis in the course of juvenile idiopathic arthritis with isolated uveitis in children - own experiences.
Reumatologia. 2018;56(3):149-154.
https://www.ncbi.nlm.nih.gov/pubmed/30042602 - Ruiz-Medrano J, Díaz-Valle D, Cuiña R, Gegúndez JA, Chhablani J, Majumder PD, Gutierrez-Bonet R.
The role of tocilizumab in the treatment of inflammatory diseases of the eye and orbit: A useful alternative.
J Fr Ophtalmol. 2018 Sep 11. pii: S0181-5512(18)30282-1. doi: 10.1016/j.jfo.2018.02.006. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30217605 - Multicenter Uveitis Steroid Treatment Trial Research Group; Writing Committee:, Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA.
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Ophthalmology. 2018 Sep 20. pii: S0161-6420(18)31133-3. doi: 10.1016/j.ophtha.2018.08.021. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30269924 - Kulik U, Wiklund A, Kugelberg M, Lundvall A.
Long-term results after primary intraocular lens implantation in children with juvenile idiopathic arthritis-associated uveitis.
Eur J Ophthalmol. 2018 Sep 12:1120672118799623. doi: 10.1177/1120672118799623. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30207174 - Baghdasaryan E, Tepelus TC, Marion KM, Huang J, Huang P, Sadda SR, Lee OL.
Analysis of ocular inflammation in anterior chamber-involving uveitis using swept-source anterior segment OCT.
Int Ophthalmol. 2018 Sep 20. doi: 10.1007/s10792-018-1005-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30238391 - Ma S, Rogers SL, Hall AJ, Hodgson L, Brennan J, Stawell R, Lim LL.
Sarcoidosis related uveitis: Clinical presentations, disease course and rates of systemic disease progression after uveitis diagnosis.
Am J Ophthalmol. 2018 Sep 20. pii: S0002-9394(18)30532-4. doi: 10.1016/j.ajo.2018.09.013. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30243930 - Curragh DS, McAvoy CE, Rooney M, McLoone E.
Post-streptococcal uveitis syndrome in a Caucasian population: a case series.
Eye (Lond). 2018 Sep 18. doi: 10.1038/s41433-018-0214-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30228367 - Richard Colmant G, Kodjikian L, De Parisot De Bernecourt A, Guillaud M, Gerfaud-Valentin M, Denis P, Broussolle C, Jamilloux Y, Sève P.
Uveitis of Unknown Etiology: Clinical and Outcome features. A Retrospective Analysis of 355 Patients.
Ocul Immunol Inflamm. 2018 Sep 20:1-8. doi: 10.1080/09273948.2018.1522356. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30234412 - Agrawal R, Gunasekeran DV, Agarwal A, Carreño E, Aggarwal K, Gupta B, et al.
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis.
Ocul Immunol Inflamm. 2018 Aug 29:1-11. doi: 10.1080/09273948.2018.1489061. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30156979 - Teixeira-Lopes F, Alfarroba S, Dinis A, Gomes MC, Tavares A.
Ocular tuberculosis - A closer look to an increasing reality.
Pulmonology. 2018 Sep - Oct;24(5):289-293
https://www.ncbi.nlm.nih.gov/pubmed/30293580
- Abd El Latif E MD, Fayez Goubran W MD, El Gemai EEDM MD, Habib AE MD, Abdelbaki AM MD, Ammar H MD, Seleet M MD.
Pattern of Childhood Uveitis in Egypt.
Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1502325. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30148647 - Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, Guly CM.
Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy.
Pediatr Rheumatol Online J. 2018 Aug 6;16(1):51. doi: 10.1186/s12969-018-0266-5.
https://www.ncbi.nlm.nih.gov/pubmed/30081917 - Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.
https://www.ncbi.nlm.nih.gov/pubmed/29657140 - Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.
https://www.ncbi.nlm.nih.gov/pubmed/29592918 - Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M,Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15.
https://www.ncbi.nlm.nih.gov/pubmed/29303704
- Quartier P, Baptiste A, Despert V, Allain-Launay E, Koné-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B, ADJUVITEStudy Group.
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
Ann Rheum Dis. 2018 Jul;77(7):1003-1011. doi: 10.1136/annrheumdis-2017-212089. Epub 2017 Dec 23.
https://www.ncbi.nlm.nih.gov/pubmed/29275333 - Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, Guly CM.
Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy.
Pediatr Rheumatol Online J. 2018 Aug 6;16(1):51. doi: 10.1186/s12969-018-0266-5.
https://www.ncbi.nlm.nih.gov/pubmed/30081917 - Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15.
https://www.ncbi.nlm.nih.gov/pubmed/29303704
- Souto FMS, Giampietro BV, Takiuti JT, Campos LMA, Hirata CE, Yamamoto JH.
Clinical features of paediatric uveitis at a tertiary referral centre in São Paulo, SP, Brazil.
Br J Ophthalmol. 2018 Jun 15. pii: bjophthalmol-2018-312313. doi: 10.1136/bjophthalmol-2018-312313
https://www.ncbi.nlm.nih.gov/pubmed/29907630 - Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.
Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4
https://www.ncbi.nlm.nih.gov/pubmed/29671190
- Atienza-Mateo B, Calvo-Río V, Beltrán E, Martínez-Costa L, Valls-Pascual E, Hernández-Garfella M, Atanes A, Cordero-Coma M, Miquel Nolla J, Carrasco-Cubero C, Loricera J, González-Vela MC, Vegas-Revenga N, Fernández-Díaz C, Demetrio-Pablo R, Domínguez-Casas LC, Luis Martín-Varillas J, Palmou-Fontana N, Hernández JL, González-Gay MÁ, Blanco R.
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
Rheumatology (Oxford). 2018 May 1;57(5):856-864. doi:10.1093/rheumatology/kex480.
https://www.ncbi.nlm.nih.gov/pubmed/29471416 - Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, Parsa MF, Zemel LS, Ronis T, Beukelman T, Cox E, Sen HN, Holland GN, Brunner HI, Lasky A, Rabinovich CE; Juvenile Idiopathic Arthritis Disease-Specific Uveitis Subcommittee of Childhood Arthritis Rheumatology Research Alliance.
Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis.
Arthritis Care Res (Hoboken). 2018 May 28. doi: 10.1002/acr.23610. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29806733 - Rosenbaum JT, Dick AD.
The Eyes Have It: A Rheumatologist's View of Uveitis.
Arthritis Rheumatol. 2018 May 23. doi: 10.1002/art.40568. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/29790291 - Walscheid K, Neekamp L, Heiligenhaus A, Weinhage T, Heinz C, Foell D.
Increased Circulating Proinflammatory T Lymphocytes in Children with Different Forms of Anterior Uveitis: Results from a Pilot Study.
Ocul Immunol Inflamm. 2018 May 17:1-10. doi: 10.1080/09273948.2018.1467464. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29771573
- Bauer D, Kasper M, Walscheid K, Koch JM, Müther PS, Kirchhof B, Heiligenhaus A, Heinz C.
Multiplex Cytokine Analysis of Aqueous Humor in Juvenile Idiopathic Arthritis-AssociatedAnterior Uveitis With or Without Secondary Glaucoma.
Front Immunol. 2018 Apr 5;9:708. doi: 10.3389/fimmu.2018.00708. eCollection 2018.
https://www.ncbi.nlm.nih.gov/pubmed/29675026 - Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2018 Apr 15. pii: jrheum.171006. doi: 10.3899/jrheum.171006. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29657140 - Leinonen S, Immonen I, Kotaniemi K.
Fluocinolone acetonide intravitreal implant (Retisert® ) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis.
Acta Ophthalmol. 2018 Apr 14. doi: 10.1111/aos.13744. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29655222 - Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, Kramer M.
The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):801-808. doi: 10.1007/s00417-018-3928-6. Epub 2018 Feb 18.
https://www.ncbi.nlm.nih.gov/pubmed/29455252 - Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
Clin Rheumatol. 2018 Apr 3. doi: 10.1007/s10067-018-4069-3. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29611087
- Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.
Consensus-based recommendations for the management of uveitis associated with juvenileidiopathic arthritis: the SHARE initiative.
Ann Rheum Dis. 2018 Mar 28. pii: annrheumdis-2018-213131. doi: 10.1136/annrheumdis-2018-213131. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29592918 - Haasnoot AJW, Schilham MW, Kamphuis S, Hissink Muller PCE, Heiligenhaus A, Foell D, Minden K, Ophoff RA, Radstake TRDJ, Den Hollander AI, Reinards THCM, Hiddingh S, Schalij-Delfos NE, Hoppenreijs EPAH, van Rossum MAJ, Wouters C, Saurenmann RK, van den Berg JM, Wulffraat NM, Ten Cate R, de Boer JH, Pulit SL, Kuiper JJW.
An amino acid motif in HLA-DRβ1 distinguishes patients with uveitis in juvenile idiopathic arthritis.
Arthritis Rheumatol. 2018 Mar 7. doi: 10.1002/art.40484. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29513936 - Acharya NR, Patel S, Homayounfar G, Enanoria WTA, Shakoor A, Chakrabarti A, Goldstein DA.
Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy.
Ocul Immunol Inflamm. 2018 Feb 16:1-7. doi: 10.1080/09273948.2018.1424341. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29451845 - Ramanan AV, Guly C.
Adalimumab for childhood onset uveitis.
Ann Rheum Dis. 2018 Feb 28. pii: annrheumdis-2017-212767. doi: 10.1136/annrheumdis-2017-212767. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29490981 - Dawson V, Dao D, Leu M, Egense Mgc A, Jinadu L, Malone L, Alexander J.
Tubulointerstitial nephritis and uveitis (TINU) with granulomatosis: a novel report of simultaneous TINU and sarcoidosis in a pediatric patient.
J AAPOS. 2018 Mar 31. pii: S1091-8531(17)31040-6. doi: 10.1016/j.jaapos.2018.02.004. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29614344 - Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, et al.
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.
Ophthalmology. 2018 Mar 27. pii: S0161-6420(17)33390-0. doi: 10.1016/j.ophtha.2018.02.020. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29602570
- Acharya NR, Patel S, Homayounfar G, Enanoria WTA, Shakoor A, Chakrabarti A, Goldstein DA.
Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy
Ocul Immunol Inflamm. 2018 Feb 16:1-7. doi: 10.1080/09273948.2018.1424341
https://www.ncbi.nlm.nih.gov/pubmed/29451845
-
Ferrara M, Eggenschwiler L, Stephenson A, Montieth A, Nakhoul N, Araùjo-Miranda R, Foster CS.
The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States.
Ocul Immunol Inflamm. 2018 Jan 15:1-8. doi: 10.1080/09273948.2017.1420202. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29333911
- Quartier P, Baptiste A, Despert V, Allain-Launay E, Koné-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B; ADJUVITE Study Group.
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
Ann Rheum Dis. 2017 Dec 23. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29275333 -
Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT.
Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1043-1046.
https://www.ncbi.nlm.nih.gov/pubmed/29148422 - Haasnoot AJW, Sint Jago NFM, Tekstra J, de Boer JH.
Impact of Uveitis on Quality of Life in Adult Patients With Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2017 Dec;69(12):1895-1902.
https://www.ncbi.nlm.nih.gov/pubmed/28217950 - Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
Clin Exp Rheumatol. 2017 Dec 15. [Epub ahead of print] Review.
https://www.ncbi.nlm.nih.gov/pubmed/29303704 - Borrego-Sanz L, Abásolo L, López-Abad C, Fernández-Gutiérrez B, García-Feijoo J, Diaz-Valle D, Pato E, Rodriguez-Rodriguez L.
Disease Remission in Children and Adolescents with Intermediate Uveitis: A Survival Analysis.
Ophthalmologica. 2017 Dec 14. doi: 10.1159/000485262. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/29241207
- Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Venerito V, Orlando I, Franceschini R, Fusco F, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.
Ocul Immunol Inflamm. 2017 Nov 3
https://www.ncbi.nlm.nih.gov/pubmed/29099660 - Papadopoulou M, Zetterberg M, Oskarsdottir S, Andersson Grönlund M.
Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
Acta Ophthalmol. 2017 Nov;95(7):741-747
https://www.ncbi.nlm.nih.gov/pubmed/28205413 - Salek SS, Pradeep A, Guly C, Ramanan AV, Rosenbaum JT.
Uveitis and Juvenile Psoriatic Arthritis or Psoriasis.
Am J Ophthalmol. 2017 Oct 31
https://www.ncbi.nlm.nih.gov/pubmed/29101009 - Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT.
Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
Clin Exp Rheumatol. 2017 Nov 14
https://www.ncbi.nlm.nih.gov/pubmed/29148422
- Kolomeyer AM, Crane ES, Tu Y, Liu D, Chu DS.
Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review.
Can J Ophthalmol. 2017 Oct;52(5):458-462. doi: 10.1016/j.jcjo.2017.01.011.
https://www.ncbi.nlm.nih.gov/pubmed/28985804 - Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Vannozzi L, Franceschini R, Bacherini D, Frediani B, Galeazzi M, Tosi GM, Cantarini L.
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.
Ocul Immunol Inflamm. 2017 Oct 5:1-6. doi: 10.1080/09273948.2017.1351573.
https://www.ncbi.nlm.nih.gov/pubmed/28981395
- Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.
Am J Ophthalmol. 2017 Sep 6. pii: S0002-9394(17)30371-9. doi: 10.1016/j.ajo.2017.08.017. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28887115 - Crowell EL, Bahr AK, Adesina OO, Kamdar AA, Kumar KS, Goldberg A.
Orbital Inflammatory Syndrome and Anterior Uveitis: A Case Series.
Ocul Immunol Inflamm. 2017 Sep 29:1-6. doi: 10.1080/09273948.2017.1349156. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28961042
- Takkar B, Venkatesh P, Gaur N, Garg SP, Vohra R, Ghose S.
Patterns of uveitis in children at the apex institute for eye care in India: analysis and review of literature.
Int Ophthalmol. 2017 Aug 31. doi: 10.1007/s10792-017-0700-6. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28861733 - Peng S, Sun X, Sun M.
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
N Engl J Med. 2017 Aug 24;377(8):789. doi: 10.1056/NEJMc1708646.
https://www.ncbi.nlm.nih.gov/pubmed/28836421 - Nordal E, Rypdal V, Christoffersen T, Aalto K, Berntson L, Fasth A, Herlin T, Nielsen S, Peltoniemi S, Straume B, Zak M, Rygg M; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.
Pediatr Rheumatol Online J. 2017 Aug 18;15(1):66. doi: 10.1186/s12969-017-0195-8.
https://www.ncbi.nlm.nih.gov/pubmed/28821293 - Sen ES, Morgan MJ, MacLeod R, Strike H, Hinchcliffe A, Dick AD, Muthusamy B, Ramanan AV.
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis.
Pediatr Rheumatol Online J. 2017 Aug 4;15(1):58. doi: 10.1186/s12969-017-0189-6.
https://www.ncbi.nlm.nih.gov/pubmed/28778202
- Sardar E, Dusser P, Rousseau A, Bodaghi B, Labetoulle M, Koné-Paut I.
Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis.
J Pediatr. 2017 Jul;186:131-137.e1. doi: 10.1016/j.jpeds.2017.03.052. Epub 2017 Apr 27.
https://www.ncbi.nlm.nih.gov/pubmed/28457525 - Sota J, Rigante D, Lopalco G, Frediani B, Franceschini R, Galeazzi M, Iannone F, Tosi GM, Fabiani C, Cantarini L.
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.
Rheumatol Int. 2017 Jul 27. doi: 10.1007/s00296-017-3775-5. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28752230
- Rosenbaum JT.
New developments in uveitis associated with HLA B27.
Curr Opin Rheumatol. 2017 Jul;29(4):298-303.
https://www.ncbi.nlm.nih.gov/pubmed/28376061 - Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
J Rheumatol. 2017 Jun;44(6):822-826.
https://www.ncbi.nlm.nih.gov/pubmed/28365583 - Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J.
Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
Int Ophthalmol. 2017 Jun;37(3):719-725.
https://www.ncbi.nlm.nih.gov/pubmed/27432171
- Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.
IL-6 blockade in the management of non-infectious uveitis.
Clin Rheumatol. 2017 May 20. [Epub ahead of print]
- Berker N, Sen E, Elgin U, Atilgan CU, Dursun E, Yilmazbas P.
Analysis of clinical features and visual outcomes of pars planitis
Int Ophthalmol. 2017 Apr 7. doi: 10.1007/s10792-017-0526-2. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28389773
- Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28365583 - Rosenbaum JT.
New developments in uveitis associated with HLA B27.
Curr Opin Rheumatol. 2017 Apr 3. doi: 10.1097/BOR.0000000000000403. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28376061
- Haasnoot AJ, Sint Jago NF, Tekstra J, de Boer JH1.
Impact of uveitis on Quality of Life in Adult patients with Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2017 Feb 19. doi: 10.1002/acr.23224. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28217950 - Papadopoulou M, Zetterberg M,, Oskarsdottir S, Andersson Grönlund M.
Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
Acta Ophthalmol. 2017 Feb 15. doi: 10.1111/aos.13388. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28205413 - Quesada-Masachs E, Caballero CM.
Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
J Rheumatol. 2017 Feb;44(2):260-261. doi: 10.3899/jrheum.160908.
https://www.ncbi.nlm.nih.gov/pubmed/28148759 - Kahwage PP, Ferriani MP, Furtado JM, de Carvalho LM, Pileggi GS, Gomes FH, Terreri MT, Magalhães CS, Pereira RM, Sacchetti SB, Marini R, Bonfá E, Silva CA, Ferriani VP.
Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey.
Clin Rheumatol. 2017 Mar;36(3):547-553. doi: 10.1007/s10067-016-3534-0. Epub 2017 Jan 9.
https://www.ncbi.nlm.nih.gov/pubmed/28070763
- LaMattina KC, Goldstein DA.
Adalimumab for the treatment of uveitis.
Expert Rev Clin Immunol. 2017 Mar;13(3):181-188. doi: 10.1080/1744666X.2017.1288097.
https://www.ncbi.nlm.nih.gov/pubmed/28140700
- Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2016 Dec;43(12):2183-2188.
https://www.ncbi.nlm.nih.gov/pubmed/27633821
- Pato E, Martin-Martinez MA, Castelló A, Méndez-Fernandez R, Muñoz-Fernández S, Cordero-Coma M, Martinez-Costa L, Valls E, Reyes M, Francisco F, Esteban M, Fonollosa A, Sanchez-Alonso F, Fernández-Espartero C, Diaz-Valle T, Carrasco JM, Beltran-Catalán E, Hernández-Garfella M, Hernández MV, Pelegrin L, Blanco R, Diaz-Valle D.
Development of an activity disease score in patients with uveitis (UVEDAI).
Rheumatol Int. 2016 Nov 4.
https://www.ncbi.nlm.nih.gov/pubmed/27815703 - Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
J Rheumatol. 2016 Nov;43(11):2068-2073.
https://www.ncbi.nlm.nih.gov/pubmed/27633826
- Breitbach M, Tappeiner C, Böhm MR, Zurek-Imhoff B, Heinz C, Thanos S, Ganser G, Heiligenhaus A.
Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis.
Graefes Arch Clin Exp Ophthalmol. 2016 Sep 30.
https://www.ncbi.nlm.nih.gov/pubmed/27687987 - Balevic SJ, Rabinovich CE.
Drug Des Devel Ther. 2016 Sep 19;10:2997-3003.
Profile of adalimumab and its potential in the treatment of uveitis.
https://www.ncbi.nlm.nih.gov/pubmed/27698552 - Haasnoot AJ, Vernie LA, Rothova A, V D Doe P, Los LI, Schalij-Delfos NE, de Boer JH.
Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
PLoS One. 2016 Oct 10;11(10):e0164312.
https://www.ncbi.nlm.nih.gov/pubmed/27723840 - Calvo-Río V, Santos-Gómez M, Calvo I, González-Fernández MI, López Montesinos B, Mesquida M, Adán A, Victoria Hernández M, Maíz O, Atanes A, Bravo B, Modesto C, Díaz-Cordovés G, Palmou-Fontana N, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.
Anti-IL6-R Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to anti-TNF therapy. A multicenter study of 25 patients.
Arthritis Rheumatol. 2016 Oct 1.
https://www.ncbi.nlm.nih.gov/pubmed/27696756 - Böhm MR, Tappeiner C, Breitbach MA, Zurek-Imhoff B, Heinz C, Heiligenhaus A.
Ocular hypotony in patients with juvenile idiopathic arthritis - associated uveitis.
Am J Ophthalmol. 2016 Sep 21.
https://www.ncbi.nlm.nih.gov/pubmed/27664701 - Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2016 Sep 15.
https://www.ncbi.nlm.nih.gov/pubmed/27633821 - Moradi A, Stroh IG, Reddy AK, Hornbeak DM, Leung TG, Burkholder BM, Thorne JE.
Risk of Hypotony in Juvenile Idiopathic Arthritis-Associated Uveitis.
Am J Ophthalmol. 2016 Sep;169:113-24.
https://www.ncbi.nlm.nih.gov/pubmed/27345732
- Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2016 Sep 15. pii: jrheum.160231. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27633821 - Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
J Rheumatol. 2016 Sep 15. pii: jrheum.151389. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27633826 - Guindolet D, Dureau P, Terrada C, Edelson C, Barjol A, Caputo G, LeHoang P, Bodaghi B.
Cataract Surgery with Primary Lens Implantation in Children with Chronic Uveitis.
Ocul Immunol Inflamm. 2016 Sep 6:1-7. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27599095 - Paovic J, Paovic P, Sredovic V, Jovanovic S
Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.
Semin Ophthalmol. 2016 Sep 14:1-8. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27628176
- Haasnoot AM, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W, Imhof SM, Radstake TR, de Boer JH.
Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis.
Arthritis Rheumatol. 2016 Jul;68(7):1769-79. doi: 10.1002/art.39621.
http://www.ncbi.nlm.nih.gov/pubmed/26866822 - Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J
Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
Int Ophthalmol. 2016 Jul 18. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27432171 - Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VV, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG.
Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Clin Exp Rheumatol. 2016 Jul-Aug;34(4):714-8. Epub 2016 Jun 22.
http://www.ncbi.nlm.nih.gov/pubmed/27385618
- García Munitis P, Ves Losada JE, Mata E.
Uveitis: when the referral is to the pediatrician.
Arch Argent Pediatr. 2016 Jun 1;114(3):272-6. doi: 10.5546/aap.2016.272.
http://www.ncbi.nlm.nih.gov/pubmed/27164341
- Couto C, Frick MM, LaMattina K, Schlaen A, Khoury M, Lopez MM, et al.
Chronic Anterior Uveitis in Children.
Ocul Immunol Inflamm. 2016 May 18:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27191963
- Clarke SL, Sen ES, Ramanan AV.
Juvenile idiopathic arthritis-associated uveitis.
Pediatr Rheumatol Online J. 2016 Apr 27;14(1):27. doi: 10.1186/s12969-016-0088-2. Review.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27121190 - Oray M, Khachatryan N, Ebrahimiadib N, Abu Samra K, Lee S, Foster CS.
Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study.
Graefes Arch Clin Exp Ophthalmol. 2016 Apr 15. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27084082 - Castiblanco C, Meese H, Foster CS.
Treatment of pediatric uveitis with adalimumab: the MERSI experience.
J AAPOS. 2016 Apr;20(2):145-7. doi: 10.1016/j.jaapos.2015.12.006.
http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27079596
- Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, et al; french uveitis network.
Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: Multicenter study from the french uveitis network.
Arthritis Rheumatol. 2016 Mar 25. doi: 10.1002/art.39667. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27015607 - Silpa-Archa S, Oray M, Preble JM, Foster CS.
Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
Acta Ophthalmol. 2016 Mar 24. doi: 10.1111/aos.13015. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27010181 - Stroh IG, Moradi A, Burkholder BM, Hornbeak DM, Leung TG, Thorne JE.
Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma inJuvenile Idiopathic Arthritis-associated Uveitis.
Ocul Immunol Inflamm. 2016 Mar 22:1-10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27003850 - Verhagen FH, Brouwer AH, Kuiper JJ, Ossewaarde-van Norel J, Ten Dam-van Loon NH, de Boer JH.
Potential Predictors of Poor Visual Outcome in Human Leukocyte Antigen-B27-Associated Uveitis.
Am J Ophthalmol. 2016 Mar 3. pii: S0002-9394(16)30074-5. doi: 10.1016/j.ajo.2016.02.024. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26940162 - Yeo TH, Ilangovan S, Keane PA, Pavesio C, Agrawal R.
Discrepancies in assessing anterior chamber activity among uveitis specialists.
Jpn J Ophthalmol. 2016 Mar 28. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27020454 - Rosenbaum JT, Lin P, Asquith M.
Does the Microbiome Cause B27-related Acute Anterior Uveitis?
Ocul Immunol Inflamm. 2016 Mar 22:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27002532 - Phatak S, Lowder C, Pavesio C.
Controversies in intraocular lens implantation in pediatric uveitis.
J Ophthalmic Inflamm Infect. 2016 Dec;6(1):12. doi: 10.1186/s12348-016-0079-
http://www.ncbi.nlm.nih.gov/pubmed/27009616 - Abásolo L, Prieto-García Á, Díaz-Valle D, Benítez-Del-Castillo JM, Pato E, García-Feijoo J, Fernández-Gutiérrez B, Rodriguez-Rodriguez L
Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis.
Br J Ophthalmol. 2016 Mar 30. pii: bjophthalmol-2015-307774. doi: 10.1136/bjophthalmol-2015-307774. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27030281 - Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, Hirata CE, Yamamoto JH.
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.
Orphanet J Rare Dis. 2016 Mar 24;11(1):29. doi: 10.1186/s13023-016-0412-4.
http://www.ncbi.nlm.nih.gov/pubmed/27008848 - Nobre-Cardoso J, Champion E, Darugar A, Fel A, Lehoang P, Bodaghi B.
Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
Ocul Immunol Inflamm. 2016 Mar 22:1-8. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27003221
- Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS; CARRA Registry Investigators.
Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Pediatr Rheumatol Online J. 2016 Feb 16;14(1):9. doi: 10.1186/s12969-016-0069-5.
http://www.ncbi.nlm.nih.gov/pubmed/26879972 - Kolomeyer AM, Tu Y, Miserocchi E, Ranjan M, Davidow A, Chu DS.
Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2016 Feb 22:1-9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26902465 - Haasnoot AJ, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W2, Imhof SM, Radstake TR, de Boer JH.
Ocular fluid analysis in children reveals interleukin-29/interferon-λ1 as a biomarker for juvenile idiopathic arthritis associated uveitis.
Arthritis Rheumatol. 2016 Feb 11. doi: 10.1002/art.39621. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26866822 - Amin RM, Miserocchi E, Thorne JE, Hornbeak D, Jabs DA, Zierhut M.
Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.
Ocul Immunol Inflamm. 2016 Feb;24(1):81-90. doi: 10.3109/09273948.2015.1077976. Epub 2015 Dec 11.
http://www.ncbi.nlm.nih.gov/pubmed/26652068 - Grixti A, Hagan R, Nayak H, Chandna A.
Multifocal choroiditis with panuveitis in an 8-year-old boy with long standing idiopathic acute anterior uveitis.
Eur J Ophthalmol. 2016 Feb 29:0. doi: 10.5301/ejo.5000772. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26951535
- Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J.
Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
Arthritis Care Res (Hoboken). 2016 Jan;68(1):46-54. doi: 10.1002/acr.22649.
http://onlinelibrary.wiley.com/doi/10.1002/acr.22649/abstract
- Tappeiner C, Klotsche J, Schenck S, Niewerth M, Minden K, Heiligenhaus A.
Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a cross-sectional analysis of a prospective nationwide study.
Clin Exp Rheumatol. 2015 Nov-Dec;33(6):936-44.
http://www.ncbi.nlm.nih.gov/pubmed/26517055
- Sheila T. Angeles-Han, Steven Yeh, Courtney McCracken, Kirsten Jenkins, Daneka Stryker, Erica Myoung, Larry B. Vogler, Kelly Rouster-Stevens, Scott R. Lambert, Melanie J. Harrison, Sampath Prahalad and Carolyn Drews-Botsch
Using the Effects of Youngsters’ Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With Uveitis (pages 1513–1520)
Arthritis Care & Research DOI: 10.1002/acr.22627
Abstract - Ivan Foeldvari, Ingrid Becker and Gerd Horneff
Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry (pages 1529–1535)
Arthritis Care & Research
DOI: 10.1002/acr.22613
Abstract
- Haroon M, O'Rourke M, Ramasamy P, Murphy CC, FitzGerald O.
A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)
Ann Rheum Dis 2015;74:1990-5.
http://ard.bmj.com/content/74/11/1990.abstract - Gupta A, Ramanan AV
Uveitis in Children: Diagnosis and Management.
Indian J Pediatr. 2015 Sep 30. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26420255 - Angeles-Han ST, McCracken C, Yeh S, Jang SR, Jenkins K, Cope S, Bohnsack J, Hersh A, Thompson SD, Prahalad S
HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis
Invest Ophthalmol Vis Sci. 2015 Sep 1;56(10):6043-8. doi: 10.1167/iovs.15-17168.
http://www.ncbi.nlm.nih.gov/pubmed/26393471
- Simonini G, Cimaz R, Jones GT, Macfarlane GJ.
Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review.
Semin Arthritis Rheum. 2015 Oct;45(2):238-50. doi: 10.1016/j.semarthrit.2015.05.006
http://www.ncbi.nlm.nih.gov/pubmed/26164255 - Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V.
Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.
Br J Ophthalmol. 2015 Sep 22. pii: bjophthalmol-2015-306790. doi: 10.1136/bjophthalmol-2015-306790. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26396026
- Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Travers C, Rouster-Stevens K, Vogler LB, Lambert SR, Drews-Botsch C, Prahalad S.
The Association of Race with Childhood Uveitis.
Am J Ophthalmol. 2015 Aug 6. pii:S0002-9394(15)00463-8. doi: 10.1016/j.ajo.2015.08.002. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26255577 - Liang F, Terrada C, Ducos de Lahitte G, Quartier P, Lehoang P, Thorne JE, Bodaghi B.
Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.
Ocul Immunol Inflamm. 2015 Aug 19:1-6. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26171661 - Marrani E, Paganelli V, de Libero C, Cimaz R, Simonini G.
Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series.
Graefes Arch Clin Exp Ophthalmol. 2015 Aug 27. EPUB ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26311261
- Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J
Impact of anti-inflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: Longitudinal analysis from a nation-wide paediatric rheumatological database.
Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22649. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26212111
- de Groot-Mijnes JD, Dekkers J, de Visser L, Rothova A, van Loon AM, de Boer JH.
Antibody Production against B19 Virus in Ocular Fluid of JIA-Associated Uveitis Patients.
Ophthalmology. 2015 Jun;122(6):1270-1272.e1. doi: 10.1016/j.ophtha.2015.01.006.
http://www.ncbi.nlm.nih.gov/pubmed/25704320 - Rosenbaum JT.
Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.
Clin Rheumatol. 2015 Jun;34(6):999-1002. doi: 10.1007/s10067-015-2960-8.
http://www.ncbi.nlm.nih.gov/pubmed/25953065 - Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Rouster-Stevens K, Vogler LB, Lambert SR et al.
Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
Pediatr Rheumatol Online J. 2015 Jun 2;13:19. doi: 10.1186/s12969-015-0018-8.
http://www.ncbi.nlm.nih.gov/pubmed/26031738 - Sen ES, Dick AD, Ramanan AV.
Uveitis associated with juvenile idiopathic arthritis.
Nat Rev Rheumatol. 2015 Jun;11(6):338-348. doi: 10.1038/nrrheum.2015.20.
http://www.ncbi.nlm.nih.gov/pubmed/25825278
- Alejandro Rodríguez-García
Importancia de la evaluación oftalmológica en pacientes con artritis idiopática juvenil
Reumatol Clin.2015;11:133-8 - Vol. 11 Núm.03 DOI: 10.1016/j.reuma.2014.08.003
http://www.reumatologiaclinica.org/es/importancia-evaluacion-oftalmologica-pacientes-con/articulo/90411536/ - Rosa Bou, Alfredo Adán, Fátima Borrás, Beatriz Bravo, Inmaculada Calvo, Jaime De Inocencio, Jesús Díaz, Julia Escudero, Alex Fonollosa, Carmen García de Vicuña, Victoria Hernández, Rosa Merino, Jesús Peralta, María-Jesús Rúa, Pilar Tejada and Jordi Antón
Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus
Rheumatology International. Clinical and Experimental Investigations 2015
35:3231 DOI: 10.1007/s00296-015-3231-3
http://link.springer.com/article/10.1007/s00296-015-3231-3/fulltext.html
- Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
Ann Rheum Dis. 2015 Apr 29. pii: annrheumdis-2014-206747. doi: 10.1136/annrheumdis-annrheumdis-2014-206747. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25926155 - Lerman MA, Rabinovich CE.
The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.
Paediatr Drugs. 2015 Apr 17. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25893479
- Sen ES, Dick AD, Ramanan AV.
Uveitis associated with juvenile idiopathic arthritis.
Nat Rev Rheumatol. 2015 Mar 31. doi: 10.1038/nrrheum.2015.20. [Epub ahead of print] Review.
http://www.ncbi.nlm.nih.gov/pubmed/25825278
- Heiligenhaus, A; Minden, K; Föll, D; Pleyer, U
Uveitis in juvenile idiopathic arthritis.
Dtsch Arztebl Int. 2015 Feb 6;112(6):92-100.
http://www.ncbi.nlm.nih.gov/pubmed/25721436 - Bou R, Adán A, Borrás F, Bravo B, Calvo I, De Inocencio J, Díaz J, Escudero J, Fonollosa A, de Vicuña CG, Hernández V, Merino R, Peralta J, Rúa MJ, Tejada P, Antón J.
Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.
Rheumatol Int. 2015 Feb 6.
http://www.ncbi.nlm.nih.gov/pubmed/25656443 - Tappeiner C, Miserocchi E, Bodaghi B, Kotaniemi K, Mackensen F, Gerloni V, Quartier P, Lutz T, Heiligenhaus A.
Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
J Rheumatol. 2015 Feb 1.
http://www.ncbi.nlm.nih.gov/pubmed/25641892 - Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM, Schalij-Delfos NE, Los LI, Armbrust W, Zuithoff NP, de Boer JH.
Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.
Am J Ophthalmol. 2015 Feb;159(2):372-7.
http://www.ncbi.nlm.nih.gov/pubmed/25447121
- Christoph Tappeiner, Elisabetta Miserocchi, Bahram Bodaghi, Kaisu Kotaniemi, Friederike Mackensen, Valeria Gerloni, Pierre Quartier, Thomas Lutz and Arnd Heiligenhaus
Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
J Rheumatol published online before print February 1, 2015,doi:10.3899/jrheum.140410
http://www.jrheum.org/content/early/2015/01/27/jrheum.140410.abstract
- Rodríguez-García A.
Importancia de la evaluación oftalmológica en pacientes con artritis idiopática juvenil.
Reumatol Clin. 2014 Dec 2. pii: S1699-258X(14)00169-7. doi: 10.1016/j.reuma.2014.08.003. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25488285
- Hettinga YM, Verhagen FH, van Genderen M, de Boer JH.
Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands.
Acta Ophthalmol. 2014 Dec;92(8):798-804.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24975684
- Langner-Wegscheider BJ, de Smet MD
Surgical Management of Severe Complications Arising from Uveitis in Juvenile Idiopathic Arthritis
Ophthalmologica. 2014 Oct 18. [Epub ahead of print]
- Kalinina Ayuso V, Makhotkina N, van Tent-Hoeve M, de Groot-Mijnes JD, Wulffraat NM, Rothova A, de Boer JH.
Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown.
Surv Ophthalmol. 2014 September - October;59(5):517-531.
http://www.ncbi.nlm.nih.gov/pubmed/25130893
- Foeldvari I.
Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment.
Clin Rev Allergy Immunol. 2014 Aug 1. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25081063 - Bou R1, Iglesias E, Antón J.
Treatment of uveitis associated with juvenile idiopathic arthritis.
Curr Rheumatol Rep. 2014 Aug; 16(8):437. doi: 10.1007/s11926-014-0437-4.
http://www.ncbi.nlm.nih.gov/pubmed/24938442
- Interlandi E, Leccese P, Olivieri I, Latanza L.
Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
Clin Exp Rheumatol. 2014 Jul 8. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25005224 - Vastert SJ1, Bhat P, Goldstein DA.
Pathophysiology of JIA-associated Uveitis.
Ocul Immunol Inflamm. 2014 Jul 2:1-10.
http://www.ncbi.nlm.nih.gov/pubmed/24988139 - Simonini G1, Katie D, Cimaz R, Macfarlane GJ, Jones GT.
Current Evidence of Anti-TNFα treatment efficacy in childhood chronic uveitis: A systematic review and meta-analysis approach of individual drugs.
Arthritis Care Res (Hoboken). 2014 July;66(7):1073-84 doi: 10.1002/acr.22214.
http://www.ncbi.nlm.nih.gov/pubmed/24740981 - Calandra S1, Gallo MC1, Consolaro A1, Pistorio A1, Lattanzi B1, Bovis F1, Muratore V1, De Marco R1, Martini A1, Ravelli A2.
Female sex and oligoarthritis category are not risk factors for uveitis in italian children with juvenile idiopathic arthritis.
J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
http://www.ncbi.nlm.nih.gov/pubmed/24931957
- Wong MM, Anninger W.
The Pediatric Red Eye.
Pediatr Clin North Am. 2014 Jun;61(3):591-606
http://www.ncbi.nlm.nih.gov/pubmed/24852155
- Totan Y, Güler E, Guragaç FB, Dervisogullari MS, Tenlik A, Hepsen IF.
Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant.
J Pediatr Ophthalmol Strabismus. 2014 May 6;51:e25-8. doi: 10.3928/01913913-20140429-01.
http://www.ncbi.nlm.nih.gov/pubmed/24811080
- Emmi G, Silvestri E, Ciucciarelli L, Squatrito D, Emmi L.
Anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series.
Clin Exp Rheumatol. 2014 Apr 7. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24709082
- Pasadhika S, Rosenbaum JT.
Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.
Biologics. 2014 Feb 15;8:67-81.
http://www.ncbi.nlm.nih.gov/pubmed/24600203 - Tugal-Tutkun 1, Quartier P, Bodaghi B.
Disease of the Year: Juvenile Idiopathic Arthritis-associated Uveitis-Classification and Diagnostic Approach.
Ocul Immunol Inflamm. 2014 Feb;22(1):56-63. doi: 10.3109/09273948.2013.871565. Epub 2014 Jan 10.
http://www.ncbi.nlm.nih.gov/pubmed/24410427 - Pålsson S, Nyström A, Sjödell L, Jakobsson G, Byhr E, Andersson Grönlund M, Zetterberg M.
Combined Phacoemulsification, Primary Intraocular Lens Implantation, and Pars Plana Vitrectomy in Children with Uveitis.
Ocul Immunol Inflamm. 2014 Feb 24. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24564567 - Angeles-Han ST, Yeh S, Vogler LB.
Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.
Int J Clin Rheumtol. 2013 Feb 1;8(1). doi: 10.2217/ijr.12.83.
http://www.ncbi.nlm.nih.gov/pubmed/24187594
- de Boer J, Steijaert A, van den Bor R, Stellato R, Ossewaarde-van Norel J.
Development of Macular Edema and Impact on Visual Acuity in Uveitis Associated with Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm. 2014 Jan 10. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24410459
- Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN.
Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders.
Ophthalmology. 2013 Dec 17. pii: S0161-6420(13)00893-2. doi: 10.1016/j.ophtha.2013.09.048. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24359625 - Kotaniemi K, Sihto-Kauppi K, Salomaa P, Säilä H, Ristolainen L, Kauppi M.
The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
Clin Exp Rheumatol. 2013 Dec 16. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24351424 - Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.
Factors Predictive of Remission of New-Onset Anterior Uveitis.
Ophthalmology. 2013 Dec 14. pii: S0161-6420(13)00886-5. doi: 10.1016/j.ophtha.2013.09.041. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24342020 - Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, McCracken C, Lopez-Benitez J, Drews-Botsch C, Prahalad S; CARRA Registry Investigators.
Risk Markers of Juvenile Idiopathic Arthritis-associated Uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.
J Rheumatol. 2013 Dec;40(12):2088-96. doi: 10.3899/jrheum.130302. Epub 2013 Nov 1.
http://www.ncbi.nlm.nih.gov/pubmed/24187099
- Hu-Torres S, Foster CS.
Disease of the Year: Juvenile Idiopathic Arthritis-Differential Diagnosis.
Ocul Immunol Inflamm.2013 Oct 9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24107146
-
Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Oktay Kaçmaz R, Levy-Clarke GA, Mills MD, Nussenblatt RB,Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.Response of Pediatric Uveitis to Tumor Necrosis Factor-a Inhibitors.J Rheumatol. 2013 Aug;40(8):1394-1403.
- Zierhut M, Heiligenhaus A, deBoer J, Cunningham ET, Tugal-Tutkun I.
Controversies in juvenile idiopathic arthritis-associated uveitis.
Ocul Immunol Inflamm. 2013 Jun;21(3):167-79. doi: 10.3109/09273948.2013.800561.
http://www.ncbi.nlm.nih.gov/pubmed/23713826
- Papadopoulou C, Kostik M, Böhm M, Nieto-Gonzalez JC, Gonzalez-Fernandez MI, Pistorio A, Martini A, Ravelli A.
Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis.
J Pediatr 2013 May 9. pii: S0022-3476(13)00323-5. doi: 10.1016/j.jpeds.2013.03.047. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23664559 - Simonini G, Paudyal P, Jones GT, Cimaz R,Macfarlane GJ.
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach.
Rheumatology 2013 May; 52:825-31.
http://www.ncbi.nlm.nih.gov/pubmed/22879466 - Sakai T, Watanabe H, Kuroyanagi K, Akiyama G, Okano K, Kohno H, Tsuneoka H.
Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
Br J Ophthalmol. 2013; 97:338-42.
http://www.ncbi.nlm.nih.gov/pubmed/23314623
-
Zannin ME, Birolo C, Gerloni VM, Miserocchi E, et al.Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry.J Rheumatol. 2013 Jan;40(1):74-9. doi: 10.3899/jrheum.120583.
- Gregory AC 2nd,Kempen JH,Daniel E et al.
Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study.
Ophthalmology.2012 Oct 11. pii: S0161-6420(12)00687-2. doi: 10.1016/j.ophtha.2012.07.052. [Epub ahead of print].
http://www.ncbi.nlm.nih.gov/pubmed/23062650
- Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V; Multinational Interdisciplinary Working Group for Uveitis in Childhood.
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1365-72. doi: 10.1002/acr.21674.
http://www.ncbi.nlm.nih.gov/pubmed/22438273
- Tappeiner C, Heinz C, Ganser G, Heiligenhaus A
Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
J Rheumatol. 2012 Jun;39(6):1294-5
http://www.ncbi.nlm.nih.gov/pubmed/22661419
